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Abstract: The PAS domain serine/threonine kinase PASKIN clearly has a metabolic function in yeast,
and the regulation of glycogen synthase supports the idea of a similar function in mammals. Surpris-
ingly, PASKIN mRNA expression in mice was detectable almost exclusively in the testis, specifically
in post-meiotic germ cells during spermatogenesis. PASKIN knock-out mice show normal growth, de-
velopment, life expectancy and fertility. Thus, even when the PASKIN mRNA expression levels are
rather low in all tissues except testis, a PASKIN function outside of the testis certainly cannot be ex-
cluded. However, considering its structural architecture, PASKIN kinase activity probably represents
the metabolically regulated effector rather than PASKIN mRNA and/or protein induction. We could
show that Paskin gene expression is not induced by glucose in pancreatic beta-cells and that glucose
stimulated insulin production is independent of PASKIN. We can exclude glucose from being a direct
activator of PASKIN in vitro, however it appears to be likely that another, yet unidentified metabolic lig-
and induces PASKIN kinase activity and target protein phosphorylation. Such an activator also explains
the lack of an obvious phenotype in Paskin knock-out mice. High fat diet feeding of mice represents
a possible PASKIN-activating condition. The partial resistance to the increase in body weight gain,
decreased triglycerides in the blood plasma and the increased glucose tolerance of HFD-fed Paskin-/-
male mice indicate a role of PASKIN in energy metabolism. AMPK, the sensor of cellular energy status
was shown to be more active in Paskin-/- mouse embryonic fibroblasts. This leads to the assumption
that PASKIN might at least partially counteract the AMPK pathway. Die Funktion von PASKIN im
Pankreas und in der Energiehomöostase PASKIN ist eine Serin/Threonin Kinase, der eine metabolische
Funktion in der Hefe nachgesagt wird, wobei es die Protein Synthese kontrolliert und den glykolytischen
Fluss anregt, indem es der Synthese von Glykogen entgegenwirkt. Auch in Säugetieren ist diese Funktion
insofern bestätigt, als dass PASKIN die Glycogen Synthase phosphoryliert. Erstaunlicherweise, konnte
eine fast ausschliessliche mRNA Expression von PASKIN im Hoden nachgewiesen werden, speziell in
postmeiotischen Keimzellen während der Spermatogenese. PASKIN knock-out Mäuse verhalten sich nor-
mal bezüglich Entwicklung, Wachstum, Lebenserwartung und Fertilität. Trozt der niedrigen Expression
von PASKIN mRNA in allen anderen Geweben, kann eine Funktion von PASKIN ausserhalb der Testikel
natürlich nicht ausgeschlossen werden. In Anbetracht seiner strukturellen Architektur, stellt wohl die
Kinasetätigkeit von PASKIN den Effektor dar, der auf Veränderungen des Metabolismus reagiert. Wir
konnten ausschliessen, dass in den ?-Zellen des Pankreas Glukose die PASKIN Genexpression anregt. Zu-
dem ist die Glukose- induzierte Insulinexpression unabhängig von PASKIN. Demzufolge kommt Glukose
als direkten Aktivator von PASKIN nicht in Frage. Es scheint jedoch sehr wahrscheinlich, dass ein bis
anhin unidentifizierter metabolischer Ligand die Akitvität von PASKIN sowie die darauffolgende Phos-
phorylierung von Zielproteinen aktiviert. Das Fehlen eines offensichtlichen Phänotyps in den Paskin
knock-out Mäusen lässt sich demnach durch das Modell erklären, dass einen Aktivator unabdingbar ist.
Ein Phänotyp wurde durch das Füttern der Paskin-/- Mäuse mit einer hochfett-Diät sichtbar. Die relativ
gerine Gewichtszunahme der Paskin-/- Mäuse, sowie der verminderte Triglycerid Spiegel im Blutplasma
und die erhöhte Glukose Toleranz der männlichen Paskin-/- Mäuse, denen 45% Fett als Futter gegeben
wurde, bestätigt eine Funktion von PASKIN im Energiemetabolismus. Eine Ursache könnte die AMPK
sein, die als Sensor des zellulären Energiestatus in primären embryonalen Mausfibroblasten von Paskin-/-
Mäusen aktiver ist als in Paskin+/+ Fibroblasten. Dies führt zu der Annahme, dass PASKIN mindestens
partiell als Antagonist von AMPK fungieren könnte.
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1 ABBREVIATIONS 
AhR   aryl hydrocarbon-receptor 
AKT   RAC serine/threonine-protein kinase, Protein kinase B (PKB) 
AMPK  AMP-activated kinase 
ARNT   aryl hydrocarbon receptor nuclear translocator 
bHLH   basic helix– loop–helix DNA-binding domain 
C3G   Rho-family guanine nucleotide exchange factor 
CAF20  Cap-associated factor 20 
CCAMK  calcium / calmodulin-dependent protein kinase  
CBP   CREB-binding protein 
CREB   cAMP response element binding protein 
ChoRE  carbohydrate response element 
ChREBP  ChoRE binding protein 
DAG   diacylglycerol 
DD   cytoplasmic death domains 
DED   death effector domains 
DISC   death inducing signaling complex 
DFX   desferrioxamine 
eEF   eukaryotic translation elongation factor 
eIF   eukaryotic translation initiation factor 
EGF   epidermal-growth-factor  
EPO   erythropoietin 
ERK1/2  extracellular response kinase-1/2 
FADD   Fas associated death domain protein 
FOXO  forkhead transcription factor 
Glc   glucose 
GLUT-1/4  glucose transporter 1/4 
Gsy2   glycogen synthase 2 
GDP   guanosine diphosphate 
GSK3β  glycogen synthase kinase 3 β  
GTP   guanosine trisphosphate 
H2AX   histone H2A variant X 
HERG  human eag-related gene 
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HIF   hypoxia-inducible factor 
HNF   hepatocyte nuclear factor 
Hsp70   heat-shock protein 70 
IGF1R  insulin-like growth factor 1 receptor 
IP3   inositol-trisphosphate 
IPF1   insulin promoter factor-1 (human), ortholog of PDX-1 
IR   insulin receptor 
IRS1/IRS2  insulin receptor substrate ½ 
IRR   insulin receptor-related receptor 
LZ   leucine zipper DNA-binding domains 
MEK   mitogen-activated, ERK-activating kinase 
MIN6   mouse insulinoma cell line 
Mlx   max-like protein X 
MODY  maturity-onset diabetes of youth 
MAPK  mitogen-activated protein kinase 
NPAS   neuronal PAS protein  
NMR   nuclear magnetic resonance 
p300   300 kDa protein, histone acetyl transferase 
PA   phosphatidic acid 
PARP   Poly (ADP-ribose) polymerase 
PAS   PER/ARNT/SIM 
PDX-1  pancreatic duodenal homeobox-1 (mouse), ortholog of IPF-1 
PDK-1  phosphatidylinositol phosphate-dependent kinase-1 
PER   Drosophila Periodic 
PGM   phosphoglucomutase 
PI3K   phosphatidylinositol 3-kinase 
PKA   protein kinase A 
PTB   phosphotyrosine-binding domains 
pVHL   von Hippel-Lindau tumor suppressor protein 
PYP   photoactive yellow protein 
p53   53 kDa tumor suppressor protein 
RTK   receptor tyrosine kinases 
RyRs    Ryanodine receptors 
SIM   Drosophila single-minded gene  
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Sds22   protein phosphatase, regulatory subunit 7 
Snf1   sucrose non-fermenting 1 protein kinase  
SOS   son-of-sevenless 
SREBP-1c  sterol response element binding protein 1c 
Tif11   translation initiation factor 1A 
Ugp1   UDP-glucose pyrophosphorylase 
VEGF   vascular endothelial growth factor 
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2 ZUSAMMENFASSUNG 
PASKIN ist eine Serin/Threonin Kinase, welche nah verwandt ist mit der AMP-aktivierten 
Kinase. Wie der Name vermuten lässt, ist PASKIN zugleich ein PAS Protein, welches 
wahrscheinlich befähigt ist, Veränderungen in der Umgebung wahrzunehmen. PASKIN wird 
eine metabolische Funktion in der Hefe zugeschrieben, wobei es die Protein Synthese 
kontrolliert und den glykolytischen Fluss anregt, indem es der Synthese von Glykogen 
entgegenwirkt. Auch in Säugetieren ist diese Funktion insofern bestätigt, als dass PASKIN 
die Glycogen Synthase phosphoryliert. Dementsprechend konnten wir mögliche PASKIN 
Zielenzyme identifizieren, die eine wichtige Rolle sowohl im glykolytischen Signalweg wie 
auch im Glykogenmetabolismus spielen (Tröger J., Eckhardt K., Wenger R. H; 
unveröffentlichte Beobachtungen). Um die Funktion von PASKIN zu untersuchen, haben wir 
das PASKIN Gen durch homologe Rekombination in embryonalen Stammzellen 
ausgeschaltet. PASKIN knock-out Mäuse verhalten sich normal bezüglich Entwicklung, 
Wachstum, Lebenserwartung und Fertilität. Erstaunlicherweise konnte eine fast 
ausschliessliche mRNA Expression von PASKIN im Hoden nachgewiesen werden, speziell in 
postmeiotischen Keimzellen während der Spermatogenese. Trotz der niedrigen Expression 
von PASKIN mRNA in allen anderen Geweben kann eine Funktion von PASKIN ausserhalb 
der Testikel natürlich nicht ausgeschlossen werden. In Anbetracht seiner strukturellen 
Architektur stellt wohl die Kinasetätigkeit von PASKIN den Effektor dar, der auf 
Veränderungen des Metabolismus reagiert. 
Wir können ausschliessen, dass in den β-Zellen des Pankreas Glukose die PASKIN 
Genexpression anregt. Zudem ist die Glukose-induzierte Insulinexpression unabhängig von 
PASKIN. Demzufolge kommt Glukose als direkter Aktivator von PASKIN nicht in Frage. Es 
scheint jedoch sehr wahrscheinlich, dass ein bis anhin unidentifizierter metabolischer Ligand 
die Akitvität von PASKIN sowie die darauffolgende Phosphorylierung von Zielproteinen 
aktiviert. Das Fehlen eines offensichtlichen Phänotyps in den Paskin knock-out Mäusen lässt 
sich demnach durch das Modell erklären, dass ein Aktivator unabdingbar ist. Wie man es von 
der Hefe her kennt, wird wohl die PASKIN Funktion nur unter veränderten 
Umgebungsbedingungen sichtbar. Folgedessen müssen PASKIN-aktivierende Bedingungen 
untersucht werden. 
Ein Phänotyp wurde durch das Füttern der Paskin-/- Mäuse mit einer hochfett-Diät sichtbar. 
Die relativ geringe Gewichtszunahme der Paskin-/- Mäuse, sowie der verminderte Triglycerid 
Spiegel im Blutplasma und die erhöhte Glukose Toleranz der männlichen Paskin-/- Mäuse, 
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denen 45% Fett als Futter gegeben wurde, bestätigt eine Funktion von PASKIN im 
Energiemetabolismus. Eine Ursache könnte die AMPK sein, die als Sensor des zellulären 
Energiestatus in primären embryonalen Mausfibroblasten von Paskin-/- Mäusen aktiver ist als 
in Paskin+/+ Fibroblasten. Dies führt zu der Annahme, dass PASKIN mindestens partiell als 
Antagonist von AMPK fungieren könnte. Überraschenderweise ist jedoch die 
Spontanaktivität in Paskin-/- Mäusen vermindert, was weitere Analysen notwendig macht, um 
die genaue Wechselwirkung von PASKIN mit AMPK zu verstehen. 
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3 SUMMARY 
The PAS domain serine/threonine kinase PASKIN clearly has a metabolic function in yeast, 
and the regulation of glycogen synthase supports the idea of a similar function in mammals. 
Accordingly, potential PASKIN targets are enzymes involved in the glycolytic pathway and 
the glycogen metabolism (Tröger J., Eckhardt K., Wenger R.H.; unpublished observations). 
Through the generation of Paskin knock-out mice we acquired the ideal tool for investigating 
mammalian PASKIN function. By homologous recombination in embryonic stem cells we 
replaced exon 10 to 14, the part which corresponds to the kinase domain, by a lacZ reporter 
gene. PASKIN knock-out mice show normal growth, development, life expectancy and 
fertility before and after backcrossing into C57BL/6. Surprisingly, PASKIN mRNA 
expression in mice was detectable almost exclusively in the testis, specifically in post-meiotic 
germ cells during spermatogenesis.  
Thus, even when the PASKIN mRNA expression levels are rather low in all tissues except 
testis, a PASKIN function outside of the testis certainly cannot be excluded. However, 
considering its structural architecture, PASKIN kinase activity probably represents the 
metabolically regulated effector rather than PASKIN mRNA and/or protein induction. We 
could show that Paskin gene expression is not induced by glucose in pancreatic β-cells [7]. 
Furthermore glucose stimulated insulin production is independent of PASKIN. We can 
exclude glucose from being a direct activator of PASKIN in vitro, however it appears to be 
likely that another, yet unidentified metabolic ligand induces PASKIN kinase activity and 
target protein phosphorylation. Such an activator also explains the lack of an obvious 
phenotype in Paskin knock-out mice. Like in yeast, PASKIN function might become apparent 
only under altered environmental conditions such as nutrient stress. Emphasis hence must be 
put on the identification of PASKIN-activating conditions.  
High fat diet feeding of mice represents a possible PASKIN-activating condition. The partial 
resistance to the increase in body weight gain, decreased triglycerides in the blood plasma and 
the increased glucose tolerance of HFD-fed Paskin-/- male mice indicate a role of PASKIN in 
energy metabolism. AMPK, the sensor of cellular energy status was shown to be more active 
in Paskin-/- mouse embryonic fibroblasts. This leads to the assumption that PASKIN might at 
least partially counteract the AMPK pathway. Surprisingly, the spontaneous activity of 
Paskin-/- mice is decreased and careful analysis towards a correlation with AMPK needs to be 
performed. 
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4 INTRODUCTION 
Adaptations to environmental stimuli are crucial for the survival of any organism. Therefore a 
sophisticated biological sensor is indispensable to allow for sensing and rapid adaptation to 
changing conditions of the cell. Over the past ten years, PAS domains have been discovered 
as important signaling modules that monitor changes in light, redox potential, oxygen partial 
pressure, voltage and small ligands. PAS proteins are found throughout all three kingdoms of 
life to control various physiological and developmental events thereby spanning phylogeny 
from bacteria to man.  
The aim of the presented thesis is to provide further insights into the physiological context of 
the mammalian PAS protein PASKIN. This integrative work focuses on PASKIN function in 
its main expression organ, the testis, in the overall energy metabolism with a main emphasis 
on the pancreatic β cells. PASKIN knock-out animals are a precious tool for revealing 
PASKIN action. 
 
 
4.1 PASKIN – a member of the PAS domain superfamily 
The PAS superfamily of proteins is functionally specialized in the cellular response to 
environmental conditions and developmental signals. The acronym PAS originates from the 
first three proteins discovered in eukaryotes to bear such a domain: the Drosophila period 
clock protein (PER), the vertebrate aryl hydrocarbon receptor nuclear translocator (ARNT), 
and Drosophila single-minded protein (SIM) [8]. PASKIN belongs to the PAS superfamily of 
proteins which is involved in inducing and regulating some of the basic adaptive mechanisms 
of the cell [9, 10]. Besides the few sensor PAS proteins reported in mammals, such as the 
HERG voltage-dependent potassium channel [11], most other PAS proteins are 
heterodimerizing to form transcription factors responding to xenobiotics [12], hypoxia [13], 
circadian rhythm [14], and carbon monoxide [15]. The evolutionarily conserved protein 
PASKIN is the first mammalian PAS-regulated protein kinase discovered most probably link 
specific sensing of environmental changes to signaling cascades [4]. Sensing might be 
facilitated by the PAS domain while signaling occurs through its serine/threonine kinase. The 
mammalian PAS protein kinase PASKIN was identified by Wenger et al. upon a BLAST 
search using the B.japonicum FixL sequence as query [4]. At the same time, S.L. McKnight 
and co-workers reported the cloning of a human cDNA identical to PASKIN and named the 
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protein PASK. We designated the protein PASKIN, to avoid confusion with PASK which 
also stands for a previously discovered unrelated kinase [16]. 
PASKIN comprises with a size of 144 kDa two PAS domains at its N-terminal part of which 
the PAS A domain seems to play a pivotal role in modulating the kinase activity. The PAS B 
domain aligns significantly weaker when comparing to all known PAS domains by using a 
Hidden Markov model-based algorithm [17]. The C-terminally located kinase domain of 
PASKIN is a typical catalytic serine/threonine kinase and may constitute a new member of 
the Snf1/5'AMP-dependent protein kinase subfamily (Fig. 1). 
 
 
Figure 1: Domain structure of human PASKIN[4].
Most of the PAS proteins are known from archea, bacteria and lower eukarya, where they are 
known to detect environmental changes in light intensity, oxygen concentration, redox 
potential and voltage. Prokaryotic PAS proteins rather contain a histidine kinase to couple 
sensing to signaling, when compared to mammalian PAS proteins. Interestingly, the fold of 
the PAS domain of PASKIN most strongly resembles the PAS domain of the bacterial oxygen 
sensor FixL. In the case of FixL, however, signaling is mediated by a histidin kinase. 
 
 
4.2 The PAS fold and its cofactors 
Since PAS domains mediate signal transduction through different mechanisms, detailed 
information about their sequences and structures is needed. The 3D folds of PAS domains are 
highly conserved while their amino acid similarity is rather limited. Half of the known PAS 
domains contain a PAC motif at the C-terminus and split the five-stranded β-sheet into two 
sections. PAS and PAC motifs do not occur independently of each other, but are parts of the 
same functional fold, separated by a linker region which is flexible in length. The subdivision 
into PAS and PAC motifs derives from the major sequential difference in the region 
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connecting these two motifs. That is the reason, why PAS fold domains range from 
approximately 60 to 250 amino acids in length [10]. Therefore, Hefti et al. aligned six 
representative 3D-structures and proposed to define the complete structure as the PAS fold 
including the PAS and the PAC motif defined by Ponting and Aravind [18, 19].  Nevertheless 
a better annotation of the PAS fold, based upon structural information rather than sequence 
information is still required. Redefining the PAS fold into several subclasses, depending upon 
template structure or cofactor, makes sense in terms of the huge variation of PAS proteins 
occurring in nature; PAS domains are found in serine/threonine kinases, histidine kinases, 
cyclic nucleotide phosphodiesterases, circadian clock proteins, voltage-activated ion channels, 
transcription factors, photoreceptors, chemoreceptors as well as regulators of responses to 
hypoxia and embryological development of the central nervous system. A huge variation in 
cofactors and ligands, which are partially required for the detection of sensory input signals, is 
also adding up to the complexity of PAS proteins. The rapid increase in available 3D 
structures of PAS fold containing proteins provided by the PDB database will help to define 
the PAS fold more accurately. Up to date there are over 70 3D PAS structures recorded. 
 
 
Figure 2: The PAS fold. Typical PAS fold consisting of a five-stranded antiparallel β sheet flanked by several 
α helices (Left)[2]. Schematic ribbon diagram of the PAS A fold (PDB 1LL8) A to I are the structural elements 
starting from the N-terminus (Right). Light blue: turn, dark blue: strand, green: helix, red: coil.
PAS domains often serve as protein/protein interaction domains. A cofactor can be necessary 
for the interaction of such protein/protein interaction domains upon an environmental 
stimulus. Such organic cofactors might therefore be involved in sensing and are located 
within the hydrophobic core of the PAS domain. Examples are heme for sensing O2 in 
bacterial enzymes [20], FMN (flavin mononucleotide) for blue-light sensing in plant 
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phototropins [21] and 4-hydroxycinnamic acid for sensing blue light in photoactive yellow 
protein [22]. 
Independent of whether or not PAS domains contain a cofactor, they all have the same typical 
α/β structure fold with several α helices flanking a five-stranded antiparallel β sheet scaffold 
to form the PAS fold (Fig.2). Therefore folding is independent of ligand binding which has as 
well been observed when analyzing the crystal structure of the ligand-free human PAS 
domain gene HERG (human ether-a-go-go-related gene) [11]. 
Amezcua et al. measured an unusual flexibility of the PASKIN backbone amino groups of Fα 
helix, FG loop and Hβ strand in solution when comparing to other PAS domains indicating 
that these are sites for binding and interaction [2]. Hβ and Fα are near the ligand binding site 
of other kinase regulating PAS domains and the FG loop is involved in the interaction of the 
kinase with the hPASKIN PAS A fold. For FixL a heme is bound within the hydrophobic 
core. The propionic acid moieties of heme directly contact the FG loop. (Fig. 3) 
 
Figure 3: Comparison of binding sites for aromatic compounds. (Left) Oxygen-binding complex of FixL 
heme domain (PDB 1DP6), green: heme, red: oxygen. (Right) hPASKIN PAS A (PDB1LL8). 
Hydrophobicity increases from blue to red  
Upon screening of over 750 organic compounds for their binding ability to hPASKIN PAS A, 
Amezcua et al. further showed that tightest binding compounds are hydrophobic in character 
and typically contain one or two aromatic rings substituted with polar groups and separated by 
a linker of variable length (0-2 atoms). The site of binding corresponds to the pockets used to 
bind heme in the FixL domain. This hydrophobic core is composed of residues from the 
flexible Fα helix and Gβ strand including residues essential for discrimination against 
differently sized ligands. In Fig. 3 the hydrophobic core is marked with a yellow circle. None 
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of the previously identified ligands for other PAS domains bind to hPASKIN PAS A with 
significant affinity. Rather a novel compound involved in carbohydrate metabolism or 
translation could be a candidate, since the yeast relatives of PASKIN regulate those pathways. 
More genetic and biochemical studies are required to identify an endogenous ligand for 
PASKIN [2]. 
 
 
4.3 Activation models for PAS domain containing proteins 
The prokaryotic histidine kinase FixL 
The nitrogen-fixing bacteria Bradyrhizobium japonicum [23] and Rhizobium meliloti [24] 
contain an oxygen sensor which is a histidine kinase termed FixL. FixL and PASKIN are, 
despite their evolutionary distance, very close concerning the PAS fold structure as well as 
the regulatory mechanism. The nature of the triggering signal, however, differs between these 
two proteins. While FixL is activated by O2 interacting with the heme iron, hPASKIN does 
not contain a heme bearing domain and thus is most likely not able to bind oxygen. Once 
oxygen binds to the heme, the porphyrin ring undergoes a structural change which 
subsequently affects as well the FG loop. By this conformational change the kinase domain is 
inactivated. As the concentration of O2 drops below 50 μM in symbiotic root nodules, FixL 
catalyzes a phosphoryl transfer from ATP to the transcription factor FixJ. Subsequently, FixJ 
activates the transcription of target genes essential to rhizobial nitrogen fixation [25, 26]. 
 
The mammalian serine/threonine kinase PASKIN 
Among all PAS domains, PASKIN PAS domain shares the highest similarity with the PAS 
domain of the oxygen sensor FixL. Once a ligand is bound, both proteins alter the structure of 
the FG loop including surrounding regions. As a consequence, those changes modulate the 
activity of the kinase domain in cis. 
The FixL histidine kinase, however, weakly matches to the intervening domain rather than to 
the serine/threonine kinase domain of PASKIN. The intervening domain corresponds to the 
mouse Paskin exon 10 to 12 and is assigned to one long open reading frame. Wenger et al. 
therefore speculate that this region is the remnant of an ancestor protein where the histidine 
kinase-like domain became inactivated during evolution [4]. This hypothesis is further 
supported by the shortened human exon 10 when compared to the mouse gene. Rutter et al. 
showed that the human PASKIN PAS A domain can specifically inhibit its own kinase 
domain in trans [17]. Amezcua et al. confirmed these data showing that the residues 
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interacting with the kinase domain are located in the FG loop proximal to the ligand binding 
cavity [2]. This indicates that modest changes in the binding cavity could regulate kinase 
activity as confirmed by experiments with site-directed mutagenesis. Small organic molecules 
regulate enzymatic activity using the PAS domain as a transducer to convert chemical signals 
into a switch of kinase activity. In an inactive state no bound ligand is present and PASKIN is 
inactive. In this state the PAS domain is inhibiting the Ser/Thr kinase. Upon ligand binding to 
the PAS A domain, a conformational change takes place. The Ser/Thr kinase is disinhibited, 
resulting in autophosphorylation of PASKIN. The activated kinase is now able to 
phosphorylate downstream targets (Fig. 4). 
Phosphorylation dependence and intramolecular PAS domain-mediated inhibition are the two 
main mechanisms of PASKIN action. Autophosphorylation of the two threonine residues 
(Thr1161, Thr1165) is necessary for efficient catalytic activity. The phosphorylation site 
T1161 corresponds to the phosphorylation residues of Snf1 and AMPK which are necessary 
for catalytic activity [27]. In nuclear extracts derived from HeLa cells another 
phosphorylation site (Ser116) of PASKIN in front of the PAS A domain was identified by 
tandem mass spectroscopy in a large scale characterization of HeLa nuclear phosphoproteins 
[28]. The N-terminally located PAS domains act as intramolecular inhibitors on the activity. 
 
 
Figure 4: Model for kinase regulation by small-molecule PAS ligands[2]. 
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The role of PAS B however, still needs to be addressed concerning the regulation of kinase 
activity. 
Further work to understand the activation model of PASKIN was performed by our group 
(Tröger et al., submitted). Tröger et al. could identify phospholipids to strongly stimulate 
PASKIN autophosphorylation in a dose-dependent manner. Phosphatidic acid alone was 
shown to be sufficient for maximum activation of PASKIN autophosphorylation. The 
presence of the charged phosphate moiety seems to be required for stimulation of PASKIN 
kinase activity which is supported by the outcome that PLD, but not PLC, is converting the 
phospholipids into a high-affinity PASKIN ligand. One therefore might hypothesize that an 
extracellular ligand is signaling via a receptor-mediated intracellular PLD pathway to regulate 
PASKIN function.  
 
 
4.4 Genetics of PASKIN 
PASKIN is evolutionarily conserved and located on chromosome 2q37.3 and 1 for human and 
mouse, respectively. No polymorphism could be tracked and PASKIN is a single-copy gene. 
Ubiquitous expression of PASKIN was detected by Northern blot analyses as well as by 
multiple tissues mRNA dot blot. Higher expression levels were found in caudate nucleus and 
putamen of the brain, in prostate and in testis while reduced levels were expressed in placenta. 
On the genetic level the intron-exon structure is conserved from mouse to human, consisting 
of 18 exons except of an untranslated, short mouse first exon at a position similar to the 
human first exon and some additional base pairs at the end of mouse exon 9 and at the 
beginning of exon 10. This adds up to additional 71 amino acids in the mouse PASKIN 
sequence encoding a 1390 amino acid protein. Accordingly, the human PASKIN cDNA 
encodes for a protein of 144 kDa which is not extensively posttranslationally modified. 
Human and mouse PASKIN are similar within the two N-terminal consensus PAS repeats and 
the C-terminal serine/threonine kinase domain, but share less similarity outside of them. The 
PAS repeats are conserved when compared with the FixL sequence, however the FixL 
histidine kinase region weakly aligns to the long exon 10 of both human and mouse PASKIN 
and not to the serine/threonine kinase region. Interestingly, only one kb lies within the start 
codon of the regulatory subunit 7 gene involved in target protein recognition of type 1 
serine/threonine protein phosphatase (PPP1R7 and Ppp1r7, respectively) and the first exon of 
PASKIN, indicating that they share the promoter region (Fig. 5). Wenger et al assume a 
bicistronic promoter activity, based on the finding that PPP1R7 as well as PASKIN are 
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ubiquitously expressed. Moreover a functional role of protein phosphatase-1 in the regulation 
of PASKIN autophosphorylation was suggested, since Sds22 colocalises with the cell types 
expressing PASKIN in vivo [29]. It might be that Sds22 is responsible for PP1-mediated 
dephosphorylation of activated PASKIN to switch off the kinase activity. There are at least 
two Sds22 isoforms coexpressed with PASKIN in mouse testis. 
 
Figure 5: Primary structure of human PASKIN. Gene structure of human PASKIN. Exons are indicated 
by grey boxes numbered according to the human sequence [4].
 
4.5 Physiological function of PASKIN 
Paskin function in yeast  
While orthologs of PASKIN are found in yeast, mammals and flies, only in yeast a functional 
role has been assigned so far. PSK1 and PSK2 are the two PASKIN orthologs in 
Saccharomyces cerevisiae which are regulating protein synthesis and glycolytic flux. 
However nutrient restriction and high temperature are necessary for the downregulation of 
protein translation and carbohydrate storage by the active PASKIN kinase. Thereby, PSK1 
and PSK2 phosphorylate three translation factors and two enzymes involved in the regulation 
of glycogen and trehalose synthesis. 
S. cerevisiae is able to use galactose as an alternative energy source. When galactose is the 
only carbon-source available, yeast is converting the sugar into glucose-6-phosphate to allow 
for glycolytic flux and ATP production. Rutter and colleagues generated a psk1 psk2 double 
yeast mutant and found a growth defect under galactose utilization combined with elevated 
temperature (39°C). This temperature-sensitive galactose utilization (galts) phenotype of the 
psk1 psk2 double mutant could be efficiently rescued with the enzymatic activity of the PSK2 
protein. In the absence of PASKIN, they conclude that increased formation of storage 
carbohydrates occurs. Overexpression of the PGM1/2 enzymes is suppressing the galts 
phenotype of the psk1 psk2 double mutant. This makes sense since Pgm enzymes favour 
conversion of G1P into G6P. 
 15
INTRODUCTION 
_________________________________________________________________________________________________________________ 
 
UDP-glucose pyrophosphorylase (Ugp1p) and glycogen synthase (Gsy2p) are both inhibited 
by PASKIN dependent phosphorylation which leads to enhanced flux of galactose toward 
glycolysis by inhibiting the accumulation of glycogen. Ugp1p catalyzes the conversion of 
glucose-1-P to UDP-glucose, which is one step removed from both glycogen and trehalose. 
Gsy2p is responsible for the direct polymerization of glycogen from UDP-glucose moieties. 
The double mutant psk1 psk2 leads to the accumulation of abnormally high levels of glycogen 
therefore maintaining Ugp1p and Gsy2p in hypophosphorylated states to favour the formation 
of storage carbohydrates. When inactivating the Psk2p phosphorylation sites of Ugp1p and 
Gsy2p, the phenotype is similar to that observed in the psk1 psk2 double mutant. PASKIN 
enhances the flux towards glycolysis by negatively regulating Ugp1p and Gsy2p (Fig. 6). A 
screen for high copy 
suppressors of the galts 
phenotype revealed a 
number of genes 
encoding translation 
factors and components 
of the translation 
apparatus. Moreover, 
upon screening for 
Psk2p substrates three 
different polypeptides 
involved in protein 
synthesis were discovered. When overexpressing PASKIN in a yeast strain lacking the 
translation initiation factor 4B (STM1), the protein synthesis deficits and the vegetative 
growth are both suppressed. Taken these findings together, PASKIN may also serve to 
regulate protein synthesis. One of the identified phosphorylation substrates is the product of 
the Caf20 (Cap-Associated Factor 20) gene which negatively regulates translation by 
blocking the assembly of the translational apparatus. Furthermore it is known that its 
mammalian homolog 4E-BP (eIF4E binding protein) is phosphorylated upon stimulation with 
Insulin and other hormonal signals, thereby releasing eIF4E and subsequently increasing 
translation rate [30]. The phosphorylation state of the 4E-BP is dependent on nutrient 
availability. When glucose and amino acid are lacking, 4E-BP phosphorylation is decreased, 
thereby slowing down protein translation. The other two identified phosphorylation targets are 
Tif11p (eukaryotic translation initiation factor 1A (eIF1a)) which mediates the transfer of 
Figure 6: Model for control of metabolic flux by Psk2, modified from 
reference [1]. 
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Met-tRNA to the 40S ribosomal subunit to form the 40S preinitiation complex and Sro9p 
which binds RNA in vitro and interacts with translation ribosomes [1].  
Products of the PSK1 and PSK2 genes are therefore assigned to regulate sugar flux and 
translation in the yeast S. cerevisiae [1]. 
 
PASKIN expression in postmeiotic germ cells during spermatogenesis 
In our Paskin-/- animals β-galactosidase activity derives from the homologous recombination 
of exon 10 to 14 with a lacZ reporter construct to create knock-out animals. Whole-mount X-
Gal staining revealed an unequal staining within different regions of the seminiferous tubules 
in PASKIN knock-out mice [29]. Since spermatogenesis occurs in synchronized waves of 
distinct developmental steps, PASKIN expression in germ cells would explain this unequal 
staining. After analyzing testis sections, PASKIN could be localized in the luminal regions 
and the interface to the cytoplasm of round and elongated spermatids. PASKIN expression is 
therefore localized to haploid germ cells. By in situ hybridisation PASKIN mRNA was found 
in spermatocytes, spermatids, and spermatozoa. With the help of recently generated 
monoclonal αPASKIN antibodies, subcellular localization was investigated [31]. PASKIN 
localizes to the cytoplasma and to the nuclei of spermatogonia and spermatocytes with a 
pattern that might match the nucleoli, at least in spermatogonia. In ejaculated human sperm 
cells, PASKIN localizes mainly to the midpiece of the tail and is absent in the nucleus. 
Neither PASKIN mRNA nor PASKIN protein is present in testis at postnatal day 12 to 15. 
Only at postnatal day 25 PASKIN mRNA levels and β-galactosidase expression strongly 
increased and the expression is stable until adulthood. PASKIN knock-out animals show 
normal growth, development and reproduction. Neither sperm production nor fertility or 
motility is affected. 
Interestingly, Sds22 mRNA expression is highest in the testis, increased during mouse 
puberty, but independent of the Paskin genotype. By immunohistochemistry, a similar 
expression pattern was revealed for Sds22 as it is known for PASKIN. 
The investigation of the endogenous function of PASKIN during spermatogenesis in vitro is 
not possible since no haploid cell culture model is available. To gather more insight into a 
possible role of PASKIN during spermatogenesis, a yeast two hybrid screening was 
performed of a human testis cDNA library (Tröger J.; manuscript in preparation). Ku70, 
inhibitor of activated STAT (iSTAT) and the transcription factor testis zinc finger protein 
(tZFP) were identified as potential interactors of PASKIN. Ku70, which is involved in a wide 
range of cellular processes such as apoptosis, DNA repair, tumor development, telomere 
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maintenance or regulation of specific gene transcription [32], could be confirmed as interactor 
in a GST pull-down assay. However Ku70, being part of the DNA-repair DNA-PK complex, 
is not a phosphorylation target of PASKIN in vitro. Its interaction with PASKIN possibly 
through its protein-protein interaction site (SAP domain) might be necessary to sense the 
status of the cell, while signaling would occur through a distinct way. A possible signaling 
cascade could occur through DNA-PKcs, which is as well part of the DNA-repair DNA-PK 
complex. Interestingly, Ku70 and Ku80 were identified as interaction partners of pancreatic 
duodenal homeobox-1 (PDX-1), while DNA-PK acts as upstream kinase [33]. 
 
PASKIN function in somatic tissues 
By a yeast two hybrid screen for novel proteins interacting with PASKIN, our group 
identified the multifunctional eukaryotic translation elongation factor eEF1A1 in a HeLa 
cDNA library [31]. eEF1A1 is a GTP-binding protein catalyzing the binding of charged 
aminoacyl-tRNA to the A-site of the ribosome and is related to the above mentioned eIF1A, a 
phosphorylation target of the yeast PASKIN homolog. The interaction with the C-terminus of 
eEF1A1 was mapped to the C-terminal part of the PAS A domain and to the kinase domain of 
PASKIN. eEF1A1 is not exclusively phosphorylated by PASKIN, but also by PKCδ, Rho-
associated kinase and S6 kinase [34-36]. Since Insulin stimulation of protein synthesis 
involves S6 kinase-dependent eEF1A1 phosphorylation, a possible role for PASKIN at the 
interface of protein translation and energy metabolism arises, as it has been established for the 
yeast PASKIN homologs (see above). 
eEF1A1 colocalises with PASKIN to the cytoplasm in HeLa cells as well as to the midpiece 
of the sperm tail. We could show that in a cell-free translation assay PASKIN increases 
protein translation. We therefore assume that translation can be regulated by PASKIN-
dependent eEF1A1 phosphorylation in somatic cells. The functional variety of eEF1A1, 
including cytoskeletal organization, signal transduction, RNA synthesis, proteasomal 
degradation of damaged proteins, apoptosis, activation of the heat-shock transcription factor 
and the implication in major diseases such as diabetes and cancer, leaves possible functional 
roles open for the PASKIN-dependent eEF1A1 phosphorylation. 
On the one hand, PASKIN is detected exclusively in the cytoplasm of baculovirus-infected 
insect cells and in transiently transfected HEK293[17]. Endogenous PASKIN however was 
detected as nucleolar pattern in spermatogonia and a more speckled nuclear pattern in 
spermatocytes and in HeLa cells. In HeLa cells endogenous PASKIN is localized in the 
cytoplasm as well. The nuclear localization of endogenous PASKIN is further confirmed by a 
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PASKIN phosphopeptide which was detected in a screen for nuclear phosphopeptides in 
HeLa cells [28]. 
On the other hand, although reported to localize to the nucleus in Trypanosoma cruzi [37], we 
detected endogenous eEF1A1 exclusively in the cytoplasm of HeLa cells and of testicular 
human germ cells [31]. Therefore, a role for the eEF1A1:PASKIN interaction in the 
cytoplasm seems very likely. More interestingly, however, is the colocalization in mature 
human spermatozoa. The spermatozoa are in a translation-silent state. Therefore, a 
translation-unrelated function can be assumed. The midpiece of the sperm tail offers with its 
highly organized structure several possible roles for the eEF1A1:PASKIN interaction either in 
cytoskeletal organization or in the regulation of energy flux in combination with the 
mitochondria. PASKIN staining did not overlap with the markers for the Golgi apparatus or 
mitochondria. Additionally, in the cytoplasmic liquid of the spermatozoa several testis-
specific isoforms of proteins are localized and which might contribute together with the 
EF1A1 and PASKIN to the response to external stimuli by regulating energy flux, heat-stress 
response and apoptosis. 
As known from the yeast homologs, PASKIN is a regulator of mammalian glycogen synthase. 
hPASKIN phosphorylates glycogen synthase in vitro at Ser-640, which is a known regulatory 
phosphosite [38]. Interestingly, the midregion of PASKIN is necessary for the 
phosphorylation of glycogen synthase in vitro. This region contains no previously recognized 
structural or functional domains or sequences. This interaction is negatively regulated by the 
PAS domain and the glycogen synthase itself. These findings show again that the metabolic 
status of the cell is playing a key role in activating PASKIN. It could be that hPASKIN 
maintains free glycogen synthase in a phosphorylated and therefore inactive form until it is 
properly localized to a glycogen particle.  
The human UCK2 protein is a further substrate of hPASK, however nothing is known 
concerning this interaction so far [38]. 
The assigned potential roles for PASKIN in somatic tissues might be confirmed and further 
characterized once the endogenous ligand for PASKIN has been identified. 
 
PASKIN function in pancreatic β-cells 
PDX-1 is a major transcription factor involved in the regulation of insulin gene expression in 
pancreatic β-cells of adults and is furthermore a key factor for normal pancreatic 
development. When glucose is abundant in the cell, PDX-1 translocates from the nuclear 
periphery to the nucleoplasm where it is active and can contribute to insulin gene expression 
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[39]. Disturbed insulin secretion leads to impaired β-cell function and is the main cause for 
the development of maturity-onset diabetes of the young 4 (MODY 4) [40]. This inherited 
form of diabetes is as well occurring, when the PDX-1 gene is inactivated. Rutter et al. report 
that exogenous glucose is involved in regulating PASKIN activity in isolated islet β-cells 
[41]. Rutter et al. microinjected a plasmid coding for WT PASKIN and saw increased 
preproinsulin promoter activity already under low glucose. By deletion of PDX-1 binding 
sites, the regulation by PASKIN or glucose of both the preproinsulin and PDX-1 promoters 
was completely absent which implicates PDX-1 as a target of PASKIN action. We showed 
that PASKIN mRNA and protein levels do not affect glucose-stimulated insulin production in 
Paskin knock-out animals [7]. Neither did in vivo experiments confirm Paskin-dependence of 
insulin regulation nor could we detect positive β-galactosidase staining in organs other than 
the testis. No differences in basal blood glucose levels and glucose tolerance were observed 
between wild-type and Paskin knock-out mice.  
There are some indications, why we did not detect PASKIN to be glucose responsive. First, 
Rutter et al. performed their experiments with overexpressed epitope-tagged kinase. 
Overexpression of PASKIN hardly had any effect on glucose metabolism and no impact at all 
on the release of stored insulin. Therefore Rutter et al. had to work with microinjected WT 
PASKIN which questions the physiological approach of these experiments. Second, only 
partly selective was the PASKIN silencing effect, since Rutter et al. saw a decrease in the 
mRNA from PDX-1 as well as from the preproinsulin mRNA in response to high glucose. 
However, it is still possible that the kinase activity of PASKIN influences energy homeostasis 
even though mRNA and protein levels do not directly affect insulin production in Paskin-/- 
animals. 
It has been reported recently, that PDX-1 is phosphorylated in vitro by purified PASKIN on a 
single threonine residue (Thr 152) [42]. Phosphorylation of PDX-1 by PASKIN seems to 
drive PDX-1 out of the nucleus. This is opposite to the suggested role of phosphorylated 
PDX-1 which enters the nucleoplasm [39]. Therefore Rutter and colleagues hypothesise that 
PASKIN must contribute to the long term stimulation of glucose, when chronic 
hyperglycaemia is inhibiting insulin secretion. Taken these results together, PASKIN 
stimulates PDX-1 expression and nuclear import to increase preproinsulin gene expression in 
pancreatic β-cells [41]. At the same time PASKIN phosphorylates PDX-1 Thr152 in vitro 
which apparently inhibits PDX-1 nuclear uptake [42]. Our group may contribute with a new 
model to overcome this contradiction. Glucose might activate an intracellular signaling 
pathway that involves phospholipase D (PLD) and subsequent increase in phosphatidic acid 
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(PA) formation. Tröger et al. showed that PA stimulates PASKIN autophosphorylation, but 
inhibits target phosphorylation as shown for eEF1A1 [43]. PDX-1 as another target of 
PASKIN might therefore as well be inhibited, allowing nuclear translocation. 
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5 PASKIN FUNCTION IN TESTIS 
5.1 Introduction 
Function of PASKIN during spermatogenesis 
The testis is an organ where profound differentiation processes take place under very low 
oxygen concentrations. Spermatogenesis is vulnerable to environmental influences, often 
resulting in male infertility due to toxic pollutants or thermal stress. The molecular 
mechanisms of these processes are not yet fully understood. 
We hypothesise that only under stress conditions PASKIN function becomes apparent, 
supported by the lack of an obvious phenotype in the Paskin-/- animals. In a similar approach, 
the function of the yeast orthologs PSK1 and PSK2 [1] was elucidated. By perturbation of 
normal testis homeostasis, PASKIN might sense the altered concentration of a still unknown 
metabolic ligand, thereby leading to interaction with and subsequent phosphorylation of the 
target protein. 
We mimicked physiological stress leading to apoptosis to simulate stress situation in 
seminiferous tubuli. Apoptosis assays were established in germinal cell cultures with the 
objective of implementation in primary cells. We used the knowledge that PAS domains are 
sensing modules and implemented various stressors in the experimental setups. We hoped to 
find differences in the susceptibility of Paskin+/+ versus Paskin-/- testis to show that PASKIN 
serves for the adaptation to environmental/metabolic stress conditions. Note that the testis is a 
highly organized tissue where spontaneous apoptosis takes place. 
 
Spermatogenesis 
The testis is specialized in sperm cell production. Germ cell-specific transcripts are expressed 
in a developmental stage-specific way [44]. These transcripts are derived from testis-specific 
genes which have a homolog in somatic cells or result from one or more testis-specific 
transcriptional start sites or splicing events [45]. In addition, some of the testis-specific 
proteins are unique to sperm cells. Enzymes and protein isoforms specific to testis include 
glycolytic enzymes, heat shock proteins, structural proteins, histone like proteins and 
transcription factors. The testes have, like the ovaries, two functions: they produce the male 
gametes or spermatozoa as component of the reproductive system, and they produce male sex 
hormones, thus being endocrine glands. Testosterone is the best-known hormone which 
stimulates development of the accessory male sexual organs. Both functions of the testicle are 
under control of gonadotropic hormones (LH, FSH) produced by the anterior pituitary. Under 
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a thick capsule, the tunica albuginea, the testis contains very fine coiled tubes called the 
seminiferous tubules. The tubes are lined with a layer of cells that produce sperm cells. The 
sperm travels from the seminiferous tubules to the rete testis located in the mediastinum testis, 
to the efferent ducts, and then to the epididymis where newly-created sperm cells mature. The 
sperm moves into the vas deferens and is eventually expelled through the urethra (Fig. 7). 
Between the seminiferous tubules special cells called Leydig cells are located, where 
testosterone and other androgens are formed. During puberty, androgen, LH and FSH 
production increase and the sex cords hollow out, forming the seminiferous tubules, and the 
germ cells start to differentiate into sperm. Throughout adulthood, androgens and FSH 
cooperatively act on Sertoli cells in the testes to support sperm production. The testes are 
located outside of the body, suspended by the spermatic cord within the scrotum. This allows 
for efficient fertile spermatogenesis in mammals, due to the fact that spermatogenic DNA 
polymerase beta and recombinase activities exhibit unique temperature optima, at a 
temperature somewhat less than core body temperature (37 °C). 
 
 
Figure 7: Inside the testis, delicate fibrous septa radiate towards the tunica albuginea and divide the 
parenchyma of the testis into about 300 lobuli testis, which communicate peripherally. Each lobule contains 1-
4 convoluted seminiferous tubules, modified from http://trc.ucdavis.edu. 
Seminiferous tubules form the mass of the testes and are the sites of spermatogenesis. 
Seminiferous tubules are lined by the seminiferous epithelium and contain a fluid-filled 
lumen, into which fully formed spermatozoa are released. The Sertoli cell cytoplasm extends 
the entire height of the epithelium because the cell serves to nurture the germ cells through 
their cycles of development and move them towards the lumen. Interconnecting Sertoli cells 
create the blood-testis barrier and therefore are able to control the entry and exit of nutrients, 
hormones etc. into the tubules of the testis. The Sertoli cell also reduces motility and 
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capacitation (initiation of the acrosome reaction) of the sperm cells so viability is maintained. 
Leydig cells are located in the interstitial tissue amongst the seminiferous tubules and 
constitute the endocrine component of the testis. As mentioned above, they synthesize and 
secrete testosterone. Leydig cells occur in clusters, which are variable in size and richly 
supplied by capillaries. As the germ cells divide and develop into different types of cells, they 
move from the basement membrane region through tight junctional complexes of adjacent 
Sertoli cells until they reside in the adluminal compartment. The germ cells develop as a 
syncytium or clonal unit connected to one another by intercellular bridges after cell division. 
This unique process of incomplete division ensures synchronous development and permits 
rapid communication between the cells by sharing products of their genes [46]. This 
synchrony of germ cell development results in large areas of the seminiferous tubule 
containing vast numbers of cells at the same level of development which are represented by 
the 16 stages of spermatogenesis. Spermatogenesis can be divided into three different phases, 
spermatocytogenesis, spermatidogenesis and spermiogenesis which is the terminal process. In 
mice, the first round of spermatogenesis starts at birth and is completed in about 34 up to 40 
days postnatally. This process involves cellular proliferation by repeated mitotic divisions, 
duplication of chromosomes, 
genetic recombination through 
cross-over, reduction-division by 
meiotic division to produce 
haploid spermatids, and terminal 
differentiation of the spermatids 
into spermatozoae.  
Spermatogenesis can as well be 
divided into three phases: 
proliferation, reduction-division, 
and differentiation. 
Spermatogonia originate in the 4th 
week of fetal development in the 
endodermal walls of the yolk sac 
and migrate to the primordium of 
the testis. Spermatogonia remain 
dormant until puberty and are 
always in contact with the basal lamina of the tubule. During spermatocytogenesis, a diploid 
Figure 8: Spermatogenesis 
(http://fig.cox.miami.edu/~cmallery/150/mitosis/lifecycle.htm) 
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spermatogonium divides mitotically to produce a diploid intermediate cell called a primary 
spermatocyte. Each primary spermatocyte duplicates its DNA and subsequently undergoes 
meiosis I to produce two haploid secondary spermatocytes. This division implicates sources 
of genetic variation, such as random inclusion of both parental chromosomes, and 
chromosomal crossover, to increase the genetic variability of the gamete. Each cell division 
from a spermatogonium to a spermatid is incomplete; the cells remain connected to one 
another by bridges of cytoplasm to allow synchronous development. It should also be noted 
that not all spermatogonia divide to produce spermatocytes, otherwise the supply would run 
out. Instead, certain types of spermatogonia divide to produce copies of them, thereby 
ensuring a constant supply of gametogonia to fuel spermatogenesis. Spermatidogenesis is the 
creation of spermatids from secondary spermatocytes. 
Secondary spermatocytes produced earlier rapidly enter 
meiosis II and divide to produce haploid spermatids. The 
brevity of this stage means that secondary spermatocytes 
are rarely seen in histological preparations. During 
spermiogenesis, the spermatids begin to grow a tail, and 
develop a thickened mid-piece, where the mitochondria 
gather and form an axoneme (highly structured 
arrangement of microtubules in all cilia). Spermatid 
DNA also undergoes packaging, becoming highly 
condensed. The DNA is packaged first with specific 
nuclear basic proteins, which are subsequently replaced 
with protamines during spermatid elongation. The 
resultant tightly packed chromatin is transcriptionally 
inactive. Specific mRNAs are however stored for later 
translation of sperm-specific proteins [47]. The Golgi 
apparatus surrounds the now condensed nucleus, 
becoming the acrosome. The acrosome contains enzymes 
important in the process of fertilization. One of the 
centrioles of the cell elongates to become the tail of the sperm. Maturation then takes place, 
which removes the remaining unnecessary cytoplasm and organelles. The excess cytoplasm is 
phagocytosed by surrounding Sertoli cells in the testes. The resulting spermatozoon is now 
mature but lacks motility, rendering it sterile. The mature spermatozoon is released after 
about 13.5 d from the protective Sertoli cells into the lumen of the seminiferous tubule in a 
 
 
Figure 9: Mouse spermatozoa. 
(http://www.popcouncil.org/projects/
BIO_AnnulusFunction.html) 
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process called spermiation. The non-motile spermatozoa is transported to the epididymis in 
testicular fluid secreted by the Sertoli cells with the aid of peristaltic contraction. In the 
epididymis the spermatozoae only partly acquires motility and becomes capable of 
fertilization. Transport of the mature spermatozoae through the remainder of the male 
reproductive system is achieved via muscle contraction rather than the recently acquired 
motility. The annulus is a ring-shaped structure at the distal end of the midpiece determining 
the junction between the midpiece and principal piece of the tail (Fig. 9). Sperms missing the 
annulus are not able to swim [48]. 
By spermatogenesis, one spermatogonium yields through one round of mitosis and two 
rounds of meiosis 8 gametes. The overall results of spermatogenesis are cell proliferation, 
maintenance of a reserve germ cell population, production of haploid gametes and genetic 
variability due to recombination of chromosomes during meiosis. Note that spermatogenesis 
in the seminiferous tubuli occurs under a high proliferation rate, suggesting considerable 
oxygen consumption. Because of the lack of blood vessels, the oxygen partial pressure in the 
lumen of these tubuli is as low as 2 mmHg [49]. Such low values for oxygen partial pressure 
are otherwise only found in the vicinity of mitochondria [49]. Therefore the testis represents 
an unique environment regarding the high division and differentiation rate within a small 
compartment at low oxygen pressure. With respect to these developmental and environmental 
challenges, it is not surprising that an unique set of specific genes or splice variants of 
common genes are expressed exclusively in the testis. For example, testis-specific isoforms of 
glycolytic enzymes are expressed during the haploid stages of spermatogenesis and are still 
active in mature spermatozoa, indicating the importance of testis-specific regulation of the 
glycolytic flux. 
During normal spermatogenesis germ cell death occurs spontaneously. On the other hand, 
induced germ cell death includes for example suppression of hormonal support or increased 
scrotal temperature. The mechanisms by which these proapoptotic stimuli activate germ cell 
apoptosis are not well understood. In order to provide some insights, the key molecular 
components of the effector pathways leading to caspase activation and increased germ cell 
apoptosis will be summarized in the following chapter. 
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Molecular players of apoptosis 
Apoptosis plays a vital role in the physiological maintenance of most tissues. It is a normal 
biological process that allows the elimination of unwanted cells through activation of the cell 
death program. The products of apoptosis are absorbed by neighboring cells without 
activation of an inflammatory response. Apoptosis may be triggered by a large variety of 
stimuli including extra-cellular 
signaling molecules (e.g. cytokines), 
intracellular signals (e.g. activated 
oncogenes), or physical stresses (e.g. 
UV light, gamma radiation). After 
receipt of an apoptotic signal, 
intracellular apoptosis-response 
proteins activate the cell death process 
through several mechanisms. These 
include initiating new gene 
expression, specific protein:protein 
interactions, and biochemical changes 
such as phosphorylation. In the second 
stage of apoptosis, the execution phase, cells undergo the classical changes associated with 
apoptosis. Cellular events include cleavage of specific cytosolic and structural proteins and 
fragmentation of DNA. Other cellular changes include the condensation and breakdown of the 
nucleus as well as mitochondrial membrane permeability changes. Mitochondrial disruption 
will ultimately result in cell death. The final stage of apoptosis involves the formation of 
membrane-bound apoptotic bodies. These are completely engulfed by surrounding cells or 
macrophages through the normal physiologic process of phagocytosis. Disassembly creates 
changes in the phospholipid content of the plasma membrane outer layer. Phosphatidylserine 
(PS) is exposed on the outer leaflet to be recognized by phagocytic cells which then engulf the 
apoptotic bodies. While apoptosis is the ordered disassembly of the cell, it can be 
distinguished from necrosis, occurring after a severe cellular insult, by the absence of an 
inflammatory response. The inflammation rises, since immune cells are attracted to the site 
where cytosolic and organellar contents by lost membrane integrity are spilled. The produced 
cytokines subsequently generate an inflammatory response. Cytosolic aspartate-specific 
proteases, called caspases, constitute a large protein family that is highly conserved among 
multicellular organisms. The family can be divided into two major subfamilies: caspases that 
 
Figure 10: The Bcl-2 family members.  
(http://www.sigmaaldrich.com) 
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are involved primarily in inflammation and have homology to caspase-1 (Interleukin-1β-
Converting Enzyme), and those caspases that are related to CED-3 (Caenorhabditis elegans 
cell death abnormality) and are primarily involved in apoptosis. Caspases are constitutively 
expressed in most cell types as inactive zymogens that are proteolytically processed before 
they gain full activity. The caspase zymogens contain several domains including an N-
terminal prodomain, a large subunit and a small subunit. Caspase activation involves cleaving 
the zymogen at a specific aspartic acid in the region between the large and small subunits and 
removing the prodomain. The active site is formed by a heterodimer containing one large and 
one small subunit, and the fully active caspase protein is a tetramer composed of two 
heterodimers. Because caspases exist as zymogens, their activity is thought to be regulated 
primarily on the post-translational level. However recent studies indicate that expression of 
the caspase-9 gene is regulated on the transcriptional level as well [50], and endoplasmic 
reticulum (ER) stress can induce expression of mouse caspase-12 in transfected cells [51]. 
Human caspase-8 and caspase-9 are involved in initiating apoptosis through two different 
signaling mechanisms and are known as initiator caspases. They can activate effector 
caspases, including caspase-3, by proteolytic processing. In turn, caspase-3 cleaves 
downstream targets and irreversibly commits the cell to the apoptotic fate. The initiator and 
the effector caspases are situated at pivotal junctions in apoptotic pathways. Poly (ADP-
ribose) polymerase (PARP) is one of the main cleavage targets of caspase-3 in vivo [52], 
therefore serving as a marker of cells undergoing apoptosis. Upon cleavage, PARP (116 kDa) 
is divided into the N-terminal DNA binding domain (24 kDa) and its C-terminal catalytic 
domain (89 kDa). It is an abundant nuclear enzyme that is involved in a number of cellular 
processes in response to environmental stress. PARP mediates predominantly the repair of 
DNA single strand breaks via the activation and recruitment of DNA repair enzymes and is 
involved in programmed cell death. The Bcl-2 protein family includes a large number of 
proteins that share common BCL-2 homology (BH) domains. Structurally, the Bcl-2 proteins 
can be divided into three groups. Group I proteins include Bcl-2, and these proteins are anti-
apoptotic. Group II and III family members are pro-apoptotic (Fig. 10). The group II family 
members contain all three of the BH domains (BH-1, BH-2, and BH-3). The group III family 
members contain only the BH-3 domain. The pro-apoptotic members of the BCL-2 family are 
implicated in permeabilizing the mitochondria outer membrane (MOM) and allowing leakage 
of mitochondrial proteins such as cytochrome c. The anti-apoptotic members of the protein 
family, such as Bcl-2, appear to protect cells from apoptosis by sequestering pro-apoptotic 
proteins or interfering with their activity [53]. 
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Activation of apoptosis 
Apoptosis can be induced in response to many external stimuli (extrinsic pathway or positive 
induction of apoptosis by ligand binding to a plasma membrane receptor) including activation 
of cell surface receptors such as Fas, TNFR1 (tumor necrosis factor receptor 1), TRAIL-R1 
(TNF-related apoptosis-inducing ligand receptor 1), TRAIL-R2, p75-NGFR (p75-nerve 
growth factor receptor) and others [54]. These death receptors have two distinct signaling 
motifs: the cytoplasmic death domains (DD) and the death effector domains (DED) that allow 
them to interact with other proteins involved in the apoptotic cascade. Ligands binding to 
these cell surface receptors are typically trimeric, related to TNF and cause aggregation of the 
receptors. This aggregation brings the cytoplasmic domains of the membrane receptors into 
close proximity and induces a conformational change allowing the assembly of the death 
inducing signaling complex (DISC) at the cytoplasmic tail of the receptors. The DISC 
comprises the receptors, the ligands as well as an adaptor protein, the Fas associated death 
domain protein (FADD). FADD binds through its C-terminal DD to the ligand-bound 
receptor and recruits procaspase-8. Procaspase-8 in turn binds to the DED of FADD via its 
own N-terminal DED domains. As a consequence of DISC formation at ligand-bound 
receptors, several molecules of procaspase-8 are brought into close proximity. One hypothesis 
suggests that the low intrinsic activity of procaspase-8 allows the procaspase-8 zymogens to 
cleave and activate each other [55]. On the other hand, it has been reported that activation of 
caspase-8 requires dimerization [56]. Active caspase-8 heterotetramers are released from 
DISC and are free to cleave and activate the effector caspase, caspase-3. In some cells, 
caspase-8 leads to an amplification loop that involves caspase-8 cleavage of the Bcl-2 protein 
family member, Bid. When Bid is cleaved it can induce Bax-mediated release of cytochrome 
c from the mitochondria, further committing the cell to apoptosis. Activation of procaspase-8 
can be blocked by FLIP which is a caspase-8 homolog without proteolytic activity. FLIP 
integrates into the DISC inhibiting apoptosis and forming inactive heterodimers with 
procaspase-8. Alternatively, the mitochondrial pathway is activated by intrinsic signals such 
as DNA damage [57]. The mitochondrial pathway involves members of the Bcl-2 family and 
can be activated either by the death receptor pathway or by other stimuli that are independent 
of death receptors including DNA damage, topoisomerase inhibition or withdrawal of trophic 
factors[58]. Many of the Group II and group II Bcl-2 family members, such as Bax, Bad and 
Bid, shuttle between the mitochondria and the other parts of the cell. Their activity is 
regulated by a variety of mechanisms including proteolytic processing, phosphorylation and 
sequestration by inhibitory proteins. Pro-apoptotic signals direct the Group II and III Bcl-2 
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family proteins to the mitochondria where the pro-apoptotic members interact with anti-
apoptotic Bcl-2 family members, including Bcl-2 and BclXL, to determine whether or not 
apoptosis will be initiated. If the pro-apoptotic proteins win, cytochrome c and other 
molecules are released from the MOM. Once cytochrome c is released from the mitochondria, 
it can interact with Apaf-1, dATP and procaspase-9 in a protein complex called the 
apoptosome. Caspase-9 is processed and activated when it its part of the apoptosome, where it 
can cleave and activate caspase-3.  
Figure 11: Signaling pathways of apoptosis, modified from Gupta et al. Immunity & Ageing 2006 3:5) 
 
Recent studies have suggested that a third pathway for activating apoptosis may involve the 
ER. In mice, caspase-12 has been implicated in an ER stress pathway that induces apoptosis. 
Caspase-12 in the mouse localizes to the ER and is cleaved in response to ER stress such as 
the accumulation of unfolded proteins [59]. Caspase-4 is a potential candidate for activating 
apoptosis through an ER stress pathway in humans [60]. Granzyme B and perforin, proteins 
released by cytotoxic T cells form transmembrane pores and trigger apoptosis, perhaps 
through cleavage of caspases. Caspase independent mechanisms of granzyme B-mediated 
apoptosis have also been suggested [61] (Fig. 11). 
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5.2 Methods 
Cell lines and culture conditions 
The human leukemia cell lines HL-60, the GC-1 spg spermatogonia (CRL-2053), and GC-2 
spd spermatocyte (CRL-2196) were cultured in DMEM (high glucose, Life Technologies, 
Inc., Gaithersburg, MD) supplemented with 10% heat-inactivated FCS (Roche Molecular 
Biochemicals, Mannheim, Germany), 100 U/ml penicillin, 100 μg/ml streptomycin in a 
humidified 5% CO2 in air atmosphere at 37°C. For heat exposure cells were splitted and 
allowed to grow for 24 h, and then exposed to 44°C for 4 h. After heat treatment, cells were 
returned to 37°C for 3 h so that apoptosis could proceed. All experiments were repeated at 
least three times. Data shown in the graphs for various parameters represent the means and 
SEM.  
 
Preparation of cell lysates and determination of DEVD-AMC cleavage 
Cells were exposed to 44°C for 4 h and back to 37°C for 3 h. At frequent intervals thereafter, 
cells were collected by centrifugation and resuspended in lysis buffer (100 mM Hepes, pH 
7.5, 10% sucrose, 0.1% CHAPS, 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride). 
Cell lysate (30 mg of protein/sample) was incubated with 12 mM of the fluorogenic peptide 
substrate DEVD-AMC in a 96-well microtiter plate at room temperature. The cleavage of 
DEVD-AMC was monitored by AMC liberation in a fluoroscan plate reader using 360 nm 
excitation and 465 nm emission wavelengths. Fluorescence was measured every 300 s during 
a 60 min period, and fluorescence units were converted to pmol amounts of AMC using a 
standard curve generated with free AMC (Sigma). Control experiments confirmed that the 
release of substrate was linear with DEVD-AMC and protein concentration. 
 
Primary cells and culture conditions 
The animals were killed by cervical dislocation. The testis was excised and the capsule 
removed. The seminiferous tubuli were incubated in BWW media (21.58 mM Na-lactate, 0.50 
mM Na-pyruvate, 100 U/ml penicillin and 100 μg/ml streptomycin, 5.56 mM Glc, 5 mg/ml 
BSA) with or without indicated concentrations of adriamycin in a 6-well plate. The tubuli 
were incubated in a humidified incubator with 5% CO2 at 30°C and 44°C, respectively. 
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Preparation of cell lysates of seminiferous tubuli 
Seminiferous tubuli were centrifuged, washed with PBS, and resuspended in 1.5 ml RIPA 
lysis buffer / g tissue (1% NP40, 0.5% sodium deoxychlate, 1% SDS in PBS, complete mini-
protease inhibitor cocktail) and stored at -80°C. 
 
Western Blot Analysis 
Total protein extracts of cultured cells were prepared using RIPA lysis buffer. Protein 
concentration was determined by the Bradford method or BCA assay using bovine serum 
albumin as a standard [62]. Protein (75 μg) was run on a polyacrylamide gel and blotted onto 
PVDF membranes by semi-dry electroblotting (Bio-Rad) with a subsequent washing step in 
TBS; membranes were stained with Ponceau S to verify equal protein loading per lane. After 
overnight blocking (5% non-fat milk powder, 0.1% Tween 20 in Tris-buffered saline), blots 
were probed for 2 h with antibodies against PARP (Cell Signaling) or actin (Sigma; diluted 
1:1000, 1:5000, respectively) and detected with horseradish peroxidase-conjugated antibodies 
(Pierce; dilution: 1:2000) and the ECL system (Pierce). 
 
 
5.3 Results 
Caspase activity measurement with DEVD-AMC fluorogenic substrate 
Oxidative-stress-induced apoptosis in GC-1/GC-2 cells 
The purpose of using GC-1 (spermatogonia) and GC-2 (spermatocytes) cell lines was to 
establish a functional apoptosis assay to be further used with primary cells of the mouse testis. 
In a first approach the cells were subjected to 
oxidative stress (H2O2) and apoptosis was 
detected upon active effector caspase-3. Caspase 
activity was detected by cleavage of a 
fluorogenic substrate comprising the caspase 
cleavage site DEVD (Asp-Glu-Val-Asp) linked 
to a fluorophore. Once the fluorophore is 
released from the substrate (Ac-DEVD-AMC) 
the fluorophore can be activated by excitation 
around its extinction maximum of 346 nm and 
the emission around its maximum of 442 nm can 
be detected in a 96-well fluorimeter. Up to 
 
Figure 12: Oxidatively stressed GC-1 cells. 
Incubation with H2O2 for 2 h following 15 min 
incubation time with DEVD-AMC, as 
determined by kinetic measurement. 
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concentrations of 0.5 mM H2O2 cells undergo apoptosis and above that concentration cells are 
becoming necrotic. In Fig. 12 apoptosis is induced up to 0.4 mM as shown by increased RFU. 
Unfortunately, the reproducibility was poor and showed even less confidence when GC-2 
cells were assayed. Therefore we concluded that these cell lines were not adequate to establish 
an apoptosis assay, since they are genetically instable. Note, that spermatocytes are derived 
from the transient secondary spermatocytes and lie between the two reduction divisions 
rendering them genetically instable [63]. 
 
Hyperthermia-induced apoptosis in HL-60 cells 
In a further effort to establish an apoptosis assay, the 
human leukaemia cell line HL-60 was assayed after heat 
exposure to 44°C according to literature Katschinski et al. 
[64]. Thermal stress resulted in significant apoptotic cell 
death as demonstrated by caspase 3 activation (Fig. 13). 
Three independent assays were performed and the optimal 
endpoint was determined to be 20 min post substrate 
addition. Subsequently, the testes from Paskin-/- and 
Paskin+/+ mice were isolated and the seminiferous tubuli 
were distributed to 6-well plates containing BWW media. Even though various stressors, like 
hyperthermia, oxidative stress and serum deprivation, were applied, the testicular lysates did 
not show any caspase activity not even with the double amount of protein used (Fig. 14). We 
assume that the lysis of the seminiferous tubuli was not complete and therefore the active 
caspase was not detectable. Harsher detergents were applied (RIPA), however they interfered 
with the emission measurement.  
 
 
Figure 13: Hyperthermia induced 
apoptosis in HL-60 cells. 
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Figure 14: Kinetic measurement of caspase 3 activity. HL-60 cells incubated under 37°C and 44°C, 
respectively, were used as positive controls. 
PASKIN FUNCTION IN TESTIS 
_________________________________________________________________________________________________________________ 
 
PARP cleavage detection in stressed seminiferous tubuli 
Different lysis buffers were tested to optimize PARP detection via Immunoblotting. When 
using Chaps as detergent, no band could be visualized for primary cells, in accordance with 
the fluorometric assay. The reducing capacity of lysis buffer containing 8 M urea (P.J. 
Ratcliff, Oxford, UK) or 6 M urea [65] precipitated DNA and led to diffuse bands on the 
Western blots. The addition of DNase I to inhibit the interference of proteins with nucleic 
acids by degrading the latter did not quite lead to the desired result, even not in combination 
with lysate sonification. The method of choice implemented RIPA lysis buffer, subsequent 
homogenization with a douncer in combination with sonification [66]. The seminiferous 
tubuli were first subjected to hyperthermia for 44°C and then moved back to 30°C for another 
3 h. In Fig. 15, the HL-60 control incubated at 44°C show extensively cleaved PARP, 
indicative of hyperthermic apoptosis, whereas the HL-60 cells incubated at 37°C show only 
background apoptosis. The seminiferous tubuli derived from Paskin-/- and Paskin+/+ mice did 
not show differences in PARP cleavage, when they are subjected to hyperthermic conditions 
versus incubation at physiological temperature. Therefore, further methods to induce 
apoptosis in seminiferous tubuli 
were applied. Longer exposure 
to hyperthermia (72 h) [67], 
glucose deprivation or 
hyperglycemia (30 mM) did not 
show any increase in the 
apoptotic rate (data not shown). 
Adriamycin is known to 
increase apoptosis in 
seminiferous tubuli [68] and is 
the trade name for doxorubicin, 
which is a DNA-interacting drug widely used in chemotherapy of a wide range of cancers. 
Doxorubicin is known to interact with DNA by intercalation and inhibition of 
macromolecular biosynthesis [69]. This inhibits the progression of the enzyme topoisomerase 
II, which unwinds DNA for transcription. Doxorubicin stabilizes the topoisomerase II 
complex after it has broken the DNA chain for replication, preventing the DNA double helix 
from being resealed and thereby stopping the process of replication. According to Suominen 
et al., 8 h treatment of the seminiferous tubuli with 0.1 μM adriamycin shows a two fold 
increase in apoptotic cells [68]. When these conditions were adapted to Paskin-/- and 
 
Figure 15: Hyperthermia induced apoptosis in Paskin-/- and 
Paskin+/+ seminiferous tubuli. 
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Paskin+/+ seminiferous tubuli, no increased PARP cleavage could be verified upon treatment 
with 0.1 μM adriamycin (Fig. 16). Subsequently adriamycin was titrated up to a concentration 
of 100 μM. Neither in Paskin-/- (Fig. 16) nor in Paskin+/+ (not shown) seminiferous tubuli a 
dose-response relationship could be established. 
 
 
Figure 16: Adriamycin induced apoptosis in Paskin-/- and Paskin+/+ seminiferous tubuli. Administration 
of 0.1 μM Adriamycin (left) and titrated concentration up to 100 μM (right). 
 
5.4 Discussion 
Different methods to quantite apoptosis were established in vitro. The first method implied 
the fluorogenic substrate Ac-DEVD-AMC for measuring cleavage activity of capase 3 after 
hydrogen peroxide treatment. In spermatogonia and spermatocyte cell lines, the 
reproducibility failed due to their genetic instability [63]. Using HL-60 cells and hyperthermia 
the assay was of use. When applied to seminiferous tubuli, the lysis buffer turned out to be 
not harsh enough for successfully extracting proteins. A harsher detergent could not be used 
because of the interference with the emission measurement. The second method implied the 
detection of cleaved PARP by Immunoblotting. Apoptosis can be quantified by comparing the 
intensity of the cleaved PARP fragment with the full length PARP lane. The basal apoptotic 
rate in untreated seminiferous tubuli was so strong, that a stressor did not significantly induce 
more PARP cleavage. In the seminiferous tubuli, where ongoing cell division and 
differentiation takes place, apoptosis is occurring spontaneously to maintain cell homeostasis. 
Efforts to lower the background apoptosis by faster handling of the tubuli, for example by 
switching from CO2 euthanizing to cervix dislocation, were not effective. Finally, a TUNEL 
assay was performed with untreated tissue sections embedded in Bouin´s solution (data not 
shown). No differences could be detected as might be the case when no stress conditions are 
applied. 
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The favoured method in use to induce apoptosis in mice in vivo is cryptorchidism. This 
medical term is referring to the absence from the scrotum of one or both testes. This usually 
represents failure of the testis to move, to "descend," during fetal development from an 
abdominal position. In laboratory mice, usually one testis is surgically translocated into the 
abdominal cavity, which results in temperature elevation and apoptosis induction. After 7 to 
14 days the testis is then removed for further experimental procedure, which is a quite long 
lasting hyperthermic induction when compared to our experimental setup. It is known that 
spermatocytes are very sensitive to damage at elevated temperatures, which might be as well 
the case for overall environmental changes. The isolation procedure and the culturing in 6-
well plates might already impose too much stress on the tubuli. Suominen et al. excised the 
tubuli and treated them as well in culture, however they used transillumination assisted 
microdissection [70] to cut 2-mm long segments containing stages III-V, VII-VIII and IX-XI 
from the mouse seminiferous epithelial cycle [71]. Suominen et al. determined apoptosis rate 
by ISEL staining and the number of apoptotic cells was calculated under light microscope. 
 
 
5.5 Conclusions 
The testis being a complex, heterogeneous tissue and highly susceptible to environmental 
changes, caused major constraints comparing spontaneous with induced apoptosis. The high 
expression of PASKIN during the postmeiotic stage of spermatogenesis in mouse testis, the 
strong nuclear PASKIN signal in spermatogonia and lower PASKIN levels in spermatocytes 
and spermatids in the mitochondrial sheath of human testis, still points towards a role for 
PASKIN in spermatozoa function. Even though no significant differences could be detected 
in sperm motility assays of Paskin-/- and Paskin+/+ sperms under normal laboratory 
conditions, the co-localisation of PASKIN and eEF1A1 in the mitochondrial sheath, which is 
implicated in motility of spermatozoa emphasises an implication. Indeed, eEF1A1 is involved 
in apoptosis [72] besides its role in protein translation. Furthermore, by screening peptide 
arrays we identified novel putative phosphorylation targets of PASKIN: the inhibitor of PP1 
and PKA type II-α regulatory chain. Both proteins are also located to the mitochondrial sheath 
and have been proposed to play a role in the motility of spermatozoa [73-75]. Protamine is 
another putative phosphorylation target of PASKIN with a unique role in haploid round 
spermatids when chromatin is compacted: somatic and testicular histones are replaced by 
various basic transition proteins that help transform the nucleosomal chromatin into smooth 
condensed chromatin fibres. The transition proteins are then replaced by the sperm nuclear 
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proteins, the protamines (Hecht, NB, 1998). Furthermore, transcription is stopped or limited 
in late elongating spermatids. Specific mRNAs are stored for later translation of sperm-
specific proteins. However, the potential phosphorylation targets of PASKIN have first to be 
confirmed in vitro to exclude false positive substrates. Nevertheless, the putative 
phosphorylation targets open a broad platform to speculate about the possible role(s) of 
PASKIN.  
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6 PASKIN FUNCTION IN PANCREAS 
6.1 Introduction 
Glucose regulated gene expression 
Glucose, independently of insulin, can regulate the expression of genes involved in 
carbohydrate metabolism. Upon entry into the cells, glucose is phosphorylated to G6P by GK 
in hepatocytes and by hexokinase in all other cells. This step is required for glucose to 
undergo glycolysis, to be used in the glycogen synthesis pathway, or to enter the pentose 
phosphate pathway. This first metabolic transformation of glucose is also required for 
generating the signal that acts in transcriptional regulation. Some reports suggest that G6P 
itself might be the signaling molecule. Alternatively, other metabolites such as xylitol 
produced by the pentose phosphate pathway or intermediates of the hexosamine biosynthetic 
pathway might also act in tissue-specific regulations [76]. The analysis of glucose signaling 
is, however, often difficult to dissociate from insulin signaling. First, the entry of glucose into 
muscle and adipose tissue cells, which are two main insulin target organs, operates through 
the translocation of the Glut4 transporter via an insulin-mediated transduction signal. In 
contrast, the expression of the glucose transporters Glut2 in the liver and pancreas, Glut3 in 
the brain, and the widely distributed Glut1 are insulin independent, and their translocation is 
constitutive. Second, in the liver and to a lesser extent in the pancreas, the initial metabolic 
modification of glucose into G6P by GK is required for transcriptional regulation by glucose 
and is strongly dependent on insulin. Thus, the actions of glucose and insulin often depend on 
each other. 
Therefore, high glucose levels influence gene expression either directly or through the 
stimulation of insulin production by the β-cells of the pancreas. Insulin acts, in part, by 
altering the activity of transcription factors and, thus, transcriptional programs in target tissues 
[11]. Several transcription factors are targets of the insulin-signaling pathways. Of these, 
SREBP-1c is of particular note [12,13], and the transcription, processing and activity of 
SREBP-1c are stimulated in the liver in response to insulin [14–16]. The transcriptional 
activator SREBP-1c, which is expressed in adipose tissue and liver, promotes de novo 
lipogenesis, so converting excess glucose to triglyceride for storage until periods of energy 
deficiency. That is how the liver functions as the main buffer, providing glucose when 
nutrients are scarce and storing glucose into triacylglycerol for longer term storage as fat. By 
this way, glucose signaling in β-cells is coupled to glucose disposal in the major metabolic 
tissues. 
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Glucose regulated gene expression in β-islet cells 
The human preproinsulin gene is a single copy gene, while rodents contain two preproinsulin 
genes. Furthermore, the regulatory DNA elements within the human promoter are different 
from the rodent orthologs [77]. Glucose stimulates insulin release, transcription of 
preproinsulin and subsequent processing and translation of the nascent mRNA [78]. These 
mechanisms are crucial to the cell for maintaining ongoing insulin stores after repeated 
glucose challenges. Upon glucose stimulation, members of the mitogen-activated protein 
kinase family, extracellular response kinase-1/2 (ERK1/2), are activated by phosphorylation 
[79]. As a consequence, the β-cell specific transcription factors PDX-1, MafA, and 
Beta2/NeuroD1 are translocated to the nucleus, where binding occurs to the promoter 
sequence of the preproinsulin gene [80]. Recruitment of histone acetyltransferases by these 
transactivators also leads to increases in histone acetylation at the insulin gene to facilitate 
transcription [81]. The transcription factors act synergistically to promote insulin gene 
transcription. PDX-1 is not only involved in the regulation of insulin gene expression in 
pancreatic β-cells, but it is as well a key factor for normal pancreatic development. Jonsson et 
al. showed that mice homozygous for a targeted mutation in the PDX-1 gene selectively lack 
a pancreas. After fetal development the mutant mice die within a few days after birth, while 
the gastrointestinal part and all other internal organs were normal in appearance [82]. The 
subcellular localization of PDX-1 is reported to be regulated by phosphorylation, which 
occurs at glucose concentration, although this model is still controversial [83, 84]. The 
kinases that regulate glucose-dependent phosphorylation of PDX-1 are not fully identified, 
but there are several candidates [42, 85]. Glucose can trigger phosphorylation of PDX-1 via 
phosphatidylinositol 3-kinase (PI3K) which induces nuclear translocation of PDX and 
increases insulin expression [39]. Other factors activated by glucose likely contribute to PDX-
1-mediated response of insulin to glucose [86]. In addition to HNF3b/FOXA2, which 
positively regulates PDX1 expression [87], other members of the HNF family are expressed 
in pancreatic β-cells (HNF1a, HNF1b, HNF4a). The maturity-onset diabetes of youth 
(MODY) is a medical condition and has highlighted the importance of this network of 
transcription factors, acting directly or indirectly on insulin gene expression [88]. Depending 
on which of the transcription factors involved in insulin gene expression is genetically 
mutated, MODY1, MODY3, MODY4 or MODY5 has been assigned. Only MODY2 is caused 
by a mutation in the enzyme glucokinase. The fact that mutations in any of these genes result 
in altered insulin secretion reveals that all of these transcription factors are crucial for the 
control of cell specificity and metabolic adjustment of insulin expression (Fig. 17). 
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Figure 17: Transcriptional regulation of the insulin gene in the presence of high glucose. The roles of 
the HNF family of proteins and the central role of the transcription factor PDX1 in the regulation of the 
expression of the insulin gene are highlighted. Gene alterations responsible for the maturity onset diabetes of 
the young (MODY) are shown in red. Insulin secretion is triggered by an increase in cytosolic ATP/ADP, 
which closes K+- channels in the plasma membrane, thereby causing membrane depolarization and opening 
of voltage-gated Ca2+-channels. The resulting rise in the cytosolic Ca2_ concentration activates exocytosis of 
insulin-containing granules. Factor X, hypothetical factor acting on insulin secretion; F6P, fructose-6-
phosphate; F1,6-P2, fructose 1,6-diphosphate; Glut, glucose transporter; G6P, glucose-6-phosphate; HNF, 
hepatocyte nuclear factor; TFs, transcription factors [6]. 
 
Glucose regulated gene expression in metabolic tissues 
Insulin and glucagon are the central regulators of blood-glucose levels in mammals, however 
glucose generates independent signals in tissues other than the endocrine pancreas. The role 
of glucose in altering gene transcription is understood best in the liver, where elevated 
glucose concentrations increase the production of enzymes that are necessary for lipogenesis 
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[27,28]. As noted above, the induction of genes that encode lipogenic enzymes depends on 
insulin and SREBP-1c. However, studies in primary hepatocytes in culture show that in 
addition to insulin, glucose must also be elevated above the fasting blood level of 5.5 mM. 
These observations have led to the identification of a specific DNA regulatory sequence in the 
promoters of several genes that encode 
lipogenic enzymes, including L-type 
pyruvate kinase (PK), S14, acetyl-CoA 
carboxylase and fatty acid synthase (Fig. 
18), which has been termed the 
carbohydrate response element (ChoRE). 
The ChoRE is composed of two, 6-bp 
motifs known as E boxes that have a 
consensus sequence of CACGTG separated 
by 5 bp [29]. Generally, E-box sequences 
are recognized by transcription factors that 
contain basic helix– loop–helix/leucine 
zipper (bHLH/LZ) DNA-binding domains 
[30]. A bHLH/LZ protein that is designated 
the ChoRE-binding protein (ChREBP) 
binds to ChoRE. Several features of ChREBP are consistent with a role as a glucose-regulated 
transcription factor. For example, the mRNA that encodes ChREBP is most abundant in liver, 
small intestine, and white and brown adipose tissue, which are the most active sites of 
lipogenesis in the body [32]. Most importantly, the cellular localization of ChREBP is 
influenced by the glucose concentration in primary hepatocytes [33]. In high-glucose 
conditions, ChREBP is predominantly nuclear, whereas in low glucose most ChREBP is in 
the cytosol. ChREBP homodimers bind poorly to DNA. Instead, it works in conjunction with 
another bHLH/LZ protein called Max-like factor X (Mlx) [34,35]. In the presence of Mlx, 
ChREBP binds to the ChoREs of genes that encode lipogenic enzyme [34]. Two ChREBP–
Mlx heterodimers bind to the two E boxes of the ChoRE and appear to interact to provide the 
unique architecture that is necessary for glucose regulation (Fig. 18).  
 
Figure 18: Binding of ChREBP-Mlx to ChoRE 
activates gene transcription in response to glucose. 
The E-box-like sequences of these four ChoREs are in 
capitals and the location of the first base in the 
sequence relative to the start site of transcription is 
indicated in brackets [5]. 
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ABSTRACT 
The PAS domain serine/threonine kinase PASKIN, or PAS kinase, links energy flux and 
protein synthesis in yeast and regulates glycogen synthase in mammals. A recent report 
suggested that PASKIN mRNA, protein and kinase activity are increased in pancreatic 
islet β-cells under hyperglycemic conditions and that PASKIN is necessary for insulin 
gene expression. We previously generated Paskin knock-out mice by targeted 
replacement of the kinase domain with the β-geo fusion gene encoding β-galactosidase 
reporter activity. Here we show that no X-Gal staining was observed in islet β-cells 
derived from Paskin knock-out mice, irrespective of the ambient glucose concentration, 
whereas adenoviral expression of the lacZ gene in β-cells showed strong X-Gal staining. 
No induction of PASKIN mRNA could be detected in insulinoma cell lines or in islet β-
cells. Increasing glucose concentrations resulted in PASKIN-independent induction of 
insulin mRNA levels and insulin release. PASKIN mRNA levels were high in testes but 
undetectable in pancreas and in islet β-cells. Finally, blood glucose levels and glucose 
tolerance following i.p. glucose injection were indistinguishable between Paskin wild-
type and knock-out mice. These results suggest that Paskin gene expression is not 
induced by glucose in pancreatic β-cells and that glucose-stimulated insulin production 
is independent of PASKIN. 
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INTRODUCTION 
Per-ARNT-Sim (PAS) domain proteins often serve as environment sensors, regulating the 
cellular metabolism and behavior of microorganisms in response to, among others, oxygen or 
light. In nitrogen-fixing Rhizobium species, for example, the oxygen sensor protein FixL 
contains a heme group within its PAS domain. Oxygen bound to heme inhibits the histidine 
kinase domain. Under oxygen-free conditions, kinase activity is de-repressed and activates 
FixJ, the master transcriptional inducer of genes involved in nitrogen fixation. 
We and others previously identified a novel mammalian PAS protein, termed PASKIN [4] or 
PAS kinase [17]. The domain architecture of PASKIN resembles that of FixL. PASKIN 
contains two PAS domains (PAS A and PAS B) and a serine/threonine kinase domain related 
to AMP kinases which might be regulated in cis by binding of so far unknown (metabolic?) 
ligands to the PAS domain [2]. Following de-repression, autophosphorylation in trans results 
in the "switch-on" of the kinase domain of PASKIN [17]. The budding yeast PASKIN 
homologs PSK1 and PSK2 phosphorylate three translation factors and two enzymes involved 
in the regulation of glycogen and trehalose synthesis, thereby coordinately controlling 
translation and sugar flux [1]. Under stress conditions (nutrient restriction combined with high 
temperature), PASKIN kinase activity results in downregulation of protein synthesis and 
carbohydrate storage in yeast. In mammalian cells, PASKIN-dependent phosphorylation 
inhibits the activity of the mammalian glycogen synthase [38].  
A recent report suggested that PASKIN kinase activity followed by mRNA and protein 
expression is increased in MIN6 cells and in isolated pancreatic β-cells after exposure to high 
glucose concentrations [41]. Increased PASKIN activity appeared to be required for glucose-
dependent transcriptional induction of the pancreatic duodenum homeobox 1 (PDX-1) 
transcription factor, leading to transcriptional induction of preproinsulin but not glucokinase 
or uncoupling protein 2 gene expression. The authors concluded that decreases in PASKIN 
activity in β cells might contribute to some forms of type 2 diabetes [41]. However, no in vivo 
data were provided in this report. 
We previously generated PASKIN null mice by targeted replacement of the kinase domain of 
the mouse Paskin gene by a lacZ-neo fusion construct in embryonic stem cells [29, 89]. 
Surprisingly, PASKIN expression is strongly upregulated in post-meiotic germ cells during 
spermatogenesis as revealed by both β-galactosidase staining as well as mRNA blotting. In 
fact, PASKIN mRNA levels in testis are several magnitudes higher than in all other organs 
tested. No other "sensory" organs, including pancreas, carotid bodies or photoreceptor cells, 
stained positive for β-galactosidase. At least under laboratory conditions, fertility as well as 
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sperm production and sperm motility were not affected in PASKIN knock-out mice. To 
examine the role of PASKIN in glucose-stimulated insulin production, we used pancreatic β-
cells derived from wild-type and knock-out mice and performed glucose tolerance tests in 
these mice. 
 
 
RESEARCH DESIGN AND METHODS 
PASKIN-deficient mice 
The generation and genotyping of PASKIN knock-out mice was described previously [29]. 
Heterozygous Paskin+/- mice were crossed with the C57BL/6 inbred strain for ten generations 
and then bred to homozygosity for the knock-out allele, containing the lacZ reporter gene. All 
animal handling followed the guidelines for the use and care of laboratory animals of the 
Bundesamt für Veterinärwesen and was approved by the Kantonales Veterinäramt Zürich (Nr. 
192/2003). 
 
Islet isolation and β-cell culture 
Male Paskin+/+ and Paskin-/- mice were sacrificed by cervical dislocation, the pancreas was 
excised and islets were either manually picked or isolated by gradient density centrifugation 
as described before [90]. Briefly, 2 ml ice-cold collagenase solution (1 PZ-U/ml NB-8, 10 
mM HEPES, 3.3 mg/ml DNaseI, 10 mM CaCl2 in Hank's balanced salt solution (HBSS), pH 
7.4) was injected into several sites of the pancreas which was then incubated for 10 to 14 
minutes in a 37°C shaking waterbath. The digestion was stopped by adding ice-cold FCS-
quenching buffer (10% FCS in 22 mM HEPES, HBSS). After two washing steps with BSA-
quenching buffer (0.5% BSA in 22 mM HEPES, HBSS) and following centrifugation at 1200 
rpm/2 minutes/4°C, the digested pancreas was filtered through medical gauze. Following 
centrifugation as above, the pellet was resuspended either in 35 ml RPMI1640 media for 
manual picking or in 5 ml 1.119 g/ml histopaque (Sigma, Buchs, Switzerland) in a 50 ml tube 
and overlaid with 5 ml 1.100 g/ml histopaque, 10 ml 1.077g/ml histopaque and 10 ml HBSS. 
The tube was centrifuged (1200 rpm/25 minutes/4°C) and the islets were collected from the 
interphase, diluted 1:1 with BSA-quenching buffer, centrifuged (1200 rpm/10 minutes/4°C), 
washed once in HBSS and resuspended in RPMI1640 supplemented with 10% FCS, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 10 mM HEPES, 11 mM D-glucose (Invitrogen, Basel, 
Switzerland). Medium was changed every 24 hours for 2 to 3 days until the islets spread and 
flattened on 35 mm plates coated with extracellular matrix (ECM) derived from bovine 
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corneal endothelial cells (Novamed, Jerusalem, Israel). To control for β-galactosidase 
expression, islets were infected with adenovirus constitutively expressing the lacZ reporter 
gene [90]. 
 
Insulin determination 
Islets were cultured in pyruvate-free RPMI1640 as above. Before glucose stimulation, islets 
were starved in medium containing 1.6 mM glucose for 30 minutes, medium was replaced 
and the islets incubated for another hour. The medium was replaced by fresh medium 
containing the desired glucose concentrations and the islets were incubated for 6 hours at 
37°C. The supernatant was collected for insulin measurments and the islets were prepared for 
X-Gal staining. Insulin concentrations were determined by RIA using the insulin-CT kit 
according to the instructions provided by the manufacturer (Schering, Baar, Switzerland).  
 
X-Gal staining and β-galactosidase assay 
Excised mouse testes or cultured, glucose-treated islets were fixed with 0.2% glutaraldehyde, 
5 mM EGTA, 2 mM MgCl2, 0.1 M Na-phosphate buffer pH 7.3, permeabilised with 0.01% 
Na-deoxycholate, 0.02% NP-40, 2 mM MgCl2, 0.1 M Na-phosphate buffer pH 7.3, and 
incubated in X-gal solution (5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.02% NP-
40, 0.01% Na-deoxycholate, 0.1 M Na-phosphate buffer pH 7.3, 0.1% X-Gal) at 37°C. β-
Galactosidase activity was determined in tissue extracts by the ONPG assay and normalized 
to protein content as described before [91]. 
 
Cell culture and glucose stimulation 
Mouse spermatogonia GC-1 and spermatocyte GC-2 [92], human testicular germ cell tumor 
NCCIT and embryonal carcinoma NTERA-2 cl.D1 (provided by S. Schweyer, Göttingen, 
Germany), mouse insulinoma MIN6 and the B1-MIN6 subline (provided by W. Moritz, 
Zürich, Switzerland; J. Rutter, Utah, USA; and P.A. Halban, Geneva, Switzerland, 
respectively), and rat insulinoma INS-1E (provided by C.B. Wollheim, Geneva, Switzerland) 
cell lines were cultured in high glucose Dulbecco's modified Eagle's medium (Sigma) as 
described previously [93]. The glucose concentration was lowered to 3 mM for 16 hours 
before incubation of cells with 3 mM or 30 mM glucose for 6 hours. 
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mRNA quantification 
Total RNA from mouse organs or cultured cells was isolated as described previously [92]. 
Mouse PASKIN, insulin and L28 mRNA was determined by RT-qPCR. Briefly, 8 μg of total 
RNA was reverse transcribed with StrataScript III (Stratagene, Amsterdam, The Netherlands) 
and qPCR was performed in duplicates with 8% of the cDNA reaction mixture using a 
SYBRGreen qPCR reagent kit on a MX3000P PCR light cycler according to the 
manufacturer's instructions (Stratagene). Primers (synthesized by Microsynth, Balgach, 
Switzerland) used were: PASKIN, hPASKINfwd 5'-ggaactgctccagtttcctg-3' and hPASKINrev 
5'-ggatctccgcttaatgacca-3'; mPASKINfwd 5'-agggtccaagaattgacgtg-3' and mPASKINrev 5'-
tgactgctcaccatcctctg-3'; rPASKINfwd 5'-tgtggactgcagtggagaag-3' and rPASKINrev 5'-
caaagaggtccaagccagag-3'; ribosomal protein L28, hL28fwd 5'-ggaactgctccagtttcctg-3' and 
hL28rev 5'-ggatctccgcttaatgacca-3'; mL28fwd 5'-ggcaaaggggtcgtggtagt-3' and mL28rev 5'-
tcagggcggtacttgttctt-3'; rL28fwd 5'-cggagcccaataatctgaag-3' and rL28rev 5'-
ttgatggtggtcctcacgta-3'; PDX-1, mPDX-1fwd 5'-gaaatccaccaaagctcacg-3' and mPDX-1rev 5'-
ttcaacatcactgccagctc-3'; glucokinase, mGckfwd 5'-tatgaagaccgccaatgtga-3' and mGckrev 5'-
tttccgccaatgatcttttc-3'; rGckfwd 5'-cagtggagcgtgaagacaaa-3' and rGckrev 5'-
cttggtccaattgaggagga-3'; insulin, mmInsfwd 5'-tggcttcttctacacacccaag-3' and mmInsrev 5'-
acaatgccacgcttctgcc-3'; rmIns1fwd 5'-cacctttgtggtcctcacct-3' and rmIns1rev 5'-
ccagttggtagagggagcag-3'; mPKfwd 5'-ttctgtctcgctaccgacct-3' and mPKrev 5'-
cctgtcaccacaatcaccag-3'; rPKfwd 5'-cgttcagcccagcttctatc-3' and rPKrev 5'-
cctgtcaccacaatcaccag-3'. Dilution series of the corresponding plasmids or gel-isolated PCR 
products were used to obtain standard curves. 
 
Immunofluorescence 
Flattened islet β-cells on ECM dishes were washed with PBS, fixed with 4% 
paraformaldehyde, permeabilized with 0.5% TritonX-100, blocked with 10% normal goat 
serum (NGS) in PBS and stained with polyclonal guinea-pig anti-insulin antibodies (Sigma) 
diluted 1:100 in 1% NGS in PBS for 30 minutes at 37°C. Bound antibodies were detected 
with FITC-conjugated goat anti-guinea-pig antibodies at 1:20 dilution (Sigma). The ECM 
plates were mounted with Kaiser's glycerol gelatine (Merck, Darmstadt, Germany) and 
analyzed by fluorescence microscopy. 
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Intraperitoneal glucose tolerance tests 
Glucose tolerance tests were performed in 6-8 and 14-16 weeks old male mice. Mice were 
fasted overnight (16 hours) and injected intraperitoneally with a saline glucose solution of 2 
g/kg body weight. Blood was obtained by puncturing the tail vein and glucose levels were 
measured using ACCU-CHEK Aviva (Roche Diagnostics, Basel, Switzerland). 
Measurements were performed before and 30, 60, 90, 120 and 150 minutes after glucose 
injection. 
 
 
RESULTS 
PASKIN mRNA is not induced by high glucose treatment of cultured cell lines 
PASKIN mRNA has been previously suggested to be induced by glucose in pancreas-derived 
MIN6 cells [41]. However, following exposure to high glucose levels (30 mM) for 6 hours, 
we could not confirm PASKIN mRNA induction in mouse MIN6 cells or rat INS-1E cells, 
while insulin secretion by MIN6 cells or pyruvate kinase mRNA in INS-1E cells were readily 
increased under high glucose concentrations. Real-time RT-PCR also did not reveal any 
glucose-dependent increase in expression of PDX-1 or the two mouse or rat insulin genes 
(data not shown). A similar pattern of constitutive insulin and PDX-1 gene expression as well 
as the glucose-dependent pyruvate kinase gene expression in INS-1E cells has been reported 
previously [94]. Moreover, neither testis-derived mouse spermatogonia GC-1 and 
spermatocyte GC-2 nor human testicular germ cell tumor cell lines NTERA and NCCIT 
significantly increased PASKIN mRNA expression following treatment with 30 mM glucose 
(data not shown). Generally, the PASKIN mRNA levels were very low in all of these cell 
culture models, suggesting that they might not represent appropriate models for PASKIN 
expression. 
 
The mouse Paskin gene is not transcriptionally activated by high glucose in cultured 
islets 
To obtain a physiologically more relevant cell culture model, pancreatic islets were isolated 
from Paskin wild-type mice as well as from Paskin knock-out mice containing a lacZ-neo 
fusion gene replacing exons 10 to 14 of the Paskin gene [29]. Expression and activity of the 
β-galactosidase reporter gene in these mice was consistent with PASKIN mRNA levels as 
analyzed by Northern blotting, demonstrating adequate representation of Paskin gene activity 
[29]. However, staining of β-cells derived from Paskin-/- mice with X-Gal did not reveal any 
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signal when compared with wild-type mice (Fig. 1A). In contrast, β-cells infected with 
adenovirus expressing a lacZ reporter gene (Fig. 1A), or testes derived from the same knock-
out but not from the wild-type mice (Fig. 1B), readily stained blue. The identity of the 
primary β-cells was confirmed by immunostaining for insulin using immunofluorescence and 
immunohistochemistry (Fig. 1C). In another set of experiments, pools of islets were prepared 
from groups of 6 Paskin+/+ or Paskin-/- mice, split into aliquots of 20 islets, exposed to various 
glucose concentrations for 6 hours, extracted and assayed for specific β-galactosidase 
activities using an in vitro assay. As shown in Fig. 1D, only background levels could be 
detected in Paskin-/- islets, corresponding to Paskin+/+ islets, which were not induced by 
treatment with high glucose concentrations. In contrast, simultaneously prepared testis 
extracts derived from Paskin-/- mice displayed at least 14-fold higher β-galactosidase 
activities than the background levels observed in Paskin+/+ testes. 
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Figure 1: Paskin gene expression in pancreatic islet β-cells derived from Paskin wild-type or knock-out 
mice. Pancreata and testes were excised from the same male mice at 6-8 weeks of age. Islets were prepared, 
cultured under high or low glucose conditions, and stained as described in Research Design and Methods. A: 
X-gal staining of islets to determine β-galactosidase activity derived from lacZ gene expression used as 
reporter gene within the Paskin locus in the Paskin-/- mice, or derived from adenoviral lacZ expression as 
control. The different X-gal incubation times are indicated. B: Examples of a control X-gal staining of testes 
derived from the same animals. C: Examples of insulin immunodetection by immunofluorescence (IF) or 
immunohistochemistry (IHC), following X-gal staining, to confirm the identity and integrity of the β-cells. 
D: In another set of experiments, β-galactosidase activities were quantitatively determined by a colorimetric 
assay using protein extracts derived from pooled β-cells kept under various glucose concentrations as 
indicated or from testes as control. The OD405 nm values were normalized to 1 μg of protein. 
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Insulin gene expression is independent of PASKIN in cultured primary β-cells 
Because not only PASKIN mRNA levels but also kinase activity has been reported to be 
induced by high glucose [29], insulin gene expression could still be regulated in a PASKIN-
dependent manner, even if the Paskin gene itself is not glucose-responsive. Therefore, pools 
of islets were prepared from groups of 8 Paskin+/+ or Paskin-/- mice, split, exposed to high or 
low glucose concentrations for 6 hours, and mRNA levels were determined by real-time RT-
PCR. However, neither glucose-induction of insulin mRNA (Fig. 2A) nor insulin release into 
the supernatant (Fig. 2B) were dependent on the presence of a functional Paskin gene. The 
genotype of the mice was confirmed by simultaneous PASKIN RT-PCR using testis-derived 
RNA which, as expected, had high PASKIN mRNA levels when isolated from Paskin+/+ 
mice, but undetectable levels when isolated from Paskin-/- mice (Fig. 2C). To test whether 
PASKIN mRNA could be induced by glucose in the major organ expressing PASKIN, 
seminiferous tubuli were excised from testis and cultured in vitro under various glucose 
conditions. Again, no significant glucose-dependent PASKIN mRNA induction could be 
observed by real-time RT-PCR (Fig. 2D). Of note, the copy number of PASKIN mRNA in 
testis is approx. 1x106/μg total RNA whereas it was below the detection limit in pancreatic 
islets (data not shown). 
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Figure 2: Insulin gene expression and insulin secretion by pancreatic islet β-cells pooled from groups 
of 8 Paskin wild-type (WT) or knock-out (KO) mice. Pancreata and testes were excised from the same 
male mice at 6-8 weeks of age. Islets were prepared, cultured under high or low glucose conditions, and 
insulin mRNA and protein secretion determined by real-time RT-PCR and RIA, respectively. Glucose 
induction of insulin mRNA (A) and insulin secretion (B) were equal in β-cells derived from Paskin wild-type 
and knock-out mice. C: Example of simultaneous PASKIN mRNA determination in testes derived from the 
same mice as used for islet preparation. "a" and "b" refer to left and right testis of the same animal. PASKIN 
mRNA was undetectable in knock-out mice (not shown). D: Lack of PASKIN mRNA induction by glucose 
in cultured tubuli seminiferi derived from 14 week old mice (mean ± SEM of n = 3 independent 
experiments; n.s., not significant with p=0.80 and 0.65, respectively, using unpaired t-tests). 
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Normal glucose tolerance in Paskin-/- mice 
In order to rule out that the in vitro cultivation of islets inadequately reflected PASKIN 
function, in vivo experiments were performed. First, endogenous PASKIN and insulin 
expression levels in organs derived from mice fed normal chow diet ad libitum were 
determined by real-time RT-PCR. As shown in Fig. 3A (top panel), PASKIN mRNA levels 
were at least 50-fold higher in the testis than in every other organ tested, confirming previous 
Northern blotting data [29]. PASKIN mRNA was undetectable in pancreas. While mRNA 
derived from pancreas, as expected, generally was of worse quality than from other organs, 
PASKIN could not be detected even when 10-fold more RNA was used for the RT reactions. 
However, high insulin mRNA levels were found in the same pancreas cDNA samples (Fig. 
3A, bottom panel). 
Glucose (2 g/kg body weight) was injected intraperitoneally into 6-8 weeks (n = 5-6 per 
group) or 14-16 weeks (n = 7 per group) old Paskin+/+ or Paskin-/- mice and blood glucose 
levels were followed at 30 minute intervals for 2.5 hours. There was no significant difference 
in glucose tolerance between Paskin wild-type and knock-out mice in either of the age groups 
(Fig. 3B). To examine basal blood glucose levels, groups of 6-8 weeks or 14-16 weeks old 
mice were either fed ad libitum or fasted overnight for 16 hours. As shown in Fig. 3C, there 
was again no significant difference between Paskin wild-type and knock-out mice, 
irrespective of their food supply. 
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Figure 3: Normal blood glucose concentrations and glucose tolerance in Paskin wild-type and knock-
out mice. A: PASKIN and insulin mRNA levels in various organs derived from C57BL/6 mice determined 
by real-time RT-PCR. B: Intraperitoneal glucose tolerance tests in 6-8 or 14-16 weeks old Paskin wild-type 
or knock-out mice. C: Blood glucose concentrations in 6-8 or 14-16 weeks old Paskin wild-type or knock-
out mice either fed ad libitum or fasted overnight for 16 hours (shown are mean ± SD values of the indicated 
number n of male mice). 
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DISCUSSION 
PASKIN is highly expressed in the testis and Paskin knock-out mice display no obvious 
phenotype and a normal fertility and lifespan [29]. Therefore, a recent report suggesting that 
PASKIN is required for glucose-induced PDX-1 and insulin gene expression was quite 
unexpected [41]. We thus back-crossed our initial Paskin knock-out strain ten times with 
C57BL/6 inbred mice in order to obtain a more homogenous genetic background and repeated 
the experiments reported by da Silva Xavier et al. [41]. We neither found PASKIN mRNA 
regulation by high glucose in various pancreatic β-cell or testicular cell lines, nor in isolated 
islets or tubuli seminiferi. One explanation for this difference might be that we used real-time 
RT-PCR rather than the probably less reliable Northern blotting for mRNA determination. 
While we were unable to demonstrate glucose-dependent induction of PDX-1 and insulin 
mRNA expression, glucose readily induced insulin release into the supernatant of MIN6 cells 
and glucose also stimulated pyruvate kinase gene expression in INS-1E cells, demonstrating 
adequate cell culture conditions. Currently, we do have no explanation for this discrepancy. 
We obtained MIN6 cells from three distinct sources, but obtained similar results with all 
batches. However, probably more important than the cultured cell lines are the results with 
cultured islets. Importantly, increasing the ambient glucose concentration resulted in a similar 
increase in insulin mRNA and insulin secretion, whether the β-cells were derived from Paskin 
wild-type or knock-out mice. This experiment probably provides the most convincing 
evidence that glucose-stimulated insulin gene expression is independent of PASKIN. Another 
argument was provided by glucose tolerance tests which showed equal blood glucose 
clearance in young as well as older Paskin wild-type and knock-out mice. We extended the 
determination of blood glucose levels to additional groups of mice fed with normal chow diet 
or fasted overnight, but again could not observe any significant difference in blood glucose 
concentrations. Thus these experiments demonstrated normal acute and chronic insulin 
function in Paskin knock-out mice in vivo, further supporting our notion that insulin 
expression is independent of PASKIN.  
PASKIN clearly has a metabolic function in yeast, and the regulation of glycogen synthase 
supports the idea of a similar function also in mammals [1, 38]. In addition, we recently 
identified enzymes of the glycolytic pathway as potential PASKIN targets (Tröger J., 
Eckhardt K., Wenger R.H.; unpublished observations). Thus, even when the PASKIN mRNA 
expression levels are rather low in all tissues except testis, a PASKIN function outside of the 
testis certainly cannot be excluded. However, considering its structural architecture, PASKIN 
kinase activity probably represents the metabolically regulated effector rather than PASKIN 
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mRNA and/or protein induction. While we can exclude glucose from being a direct activator 
of PASKIN in vitro (Tröger J., Eckhardt K., Wenger R.H.; unpublished observations), it 
appears to be likely that another, yet unidentified metabolic ligand induces PASKIN kinase 
activity and target protein phosphorylation. Such an activator also would explain the lack of 
an obvious phenotype in Paskin knock-out mice. Like in yeast, PASKIN function might 
become apparent only under altered environmental conditions such as nutrient stress. 
Emphasis hence must be put on the identification of PASKIN-activating conditions. 
Apparently, high glucose alone is not sufficient to induce PASKIN.  
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6.3 Conclusions 
PASKIN mRNA is not regulated under hyperglycaemic conditions, neither in various 
pancreatic β-cell lines, testicular cell lines nor in isolated islets or tubuli seminiferi. Exposure 
to high glucose levels (30 mM) for 6 hours did not confirm PASKIN mRNA induction in 
mouse MIN6 cells or rat INS-1E cells as suggested by da Silva Xavier et al. [41]. Insulin 
secretion by MIN6 cells and pyruvate kinase gene expression in INS-1E were increased under 
high glucose concentrations, indicative of adequate cell culture conditions. Real-time RT-
PCR also did not reveal any glucose-dependent increase in expression of PDX-1 or the two 
mouse or rat insulin genes. MIN6 cells were obtained from three different sources and the 
results were similar for all batches, including the B1-MIN6 subclone [95]. Moreover, neither 
testis-derived mouse spermatogonia GC-1 and spermatocyte GC-2 nor human testicular germ 
cell tumor cell lines NTERA and NCCIT increased PASKIN mRNA expression following 
treatment with 30 mM glucose. Furthermore, we performed alignments of all known glucose 
response elements with the PASKIN promoter and the introns 1 to 5 of Mus musculus, Rattus 
norvegicus and Homo sapiens. No conserved glucose response element was found within the 
promoter or the introns. Most convincingly an increase in insulin mRNA and insulin secretion 
in both Paskin-/- and Paskin+/+ pancreatic β-cells after exposure to high glucose but no 
increase in PASKIN mRNA was observed. Thus insulin gene expression is independent of 
PASKIN under these conditions. Glucose tolerance tests showed no evidence of deficient 
insulin secretion in PASKIN animals independent of their age. This was further supported by 
normal blood glucose in Paskin-/- and Paskin+/+ animals in fed or fasted state. We reason that 
the acute and chronic insulin function in Paskin-/- animals is normal. PASKIN mRNA 
expression levels are low in all tissues, indicating that PASKIN might play a role in energy 
homeostasis once it is activated by its corresponding ligand. However, considering PASKIN 
as a mammalian sensor protein, the kinase activity might represent the metabolically 
regulated effector rather than PASKIN mRNA and protein induction. By this model, the lack 
of an obvious phenotype in Paskin-/- animals further supports the assumption that a ligand is 
needed which activates PASKIN activity under special nutrient conditions. 
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7 PASKIN FUNCTION IN ENERGY HOMEOSTASIS 
7.1 Introduction 
The role of AMP kinase in energy homeostasis 
Based on the known effects of AMPK on carbohydrate and lipid metabolism, it becomes clear 
that this system is a major player in the development and/or treatment of obesity, diabetes, 
and the metabolic syndrome, which have reached epidemic proportions in modern 
industrialized society. AMPK is probably involved in the beneficial effects of regular exercise 
and appears to mediate many of the effects of the adipokines leptin and adiponectin, as well 
as the antidiabetic drug metformin. AMPK also appears to be involved in cancer because 
LKB1 as a direct upstream kinase of AMPK acts as tumor suppressor, and because of the 
roles of the AMPK pathway in angiogenesis, apoptosis, and senescence of tumors. There are 
also indications that the AMPK system is involved in the effects of caloric restriction on life 
span. Note, that AMPK is involved in regulating energy homeostasis on the whole body level 
as well as on the cellular levels. 
 
The protein structure 
AMPK is a heterotrimer comprising α, β, and γ subunits. Two genes each encode the catalytic 
α subunit and the regulatory β subunit. The regulatory γ subunit is encoded by 3 genes. In 
total 12 heterotrimeric combinations are possible, while splice variants give rise to further 
diversity. The 2 isoforms of the α subunit, α1 and α2, contain the kinase domain in their N-
terminal half, with the C-terminal regions being required to form a complex with the β and γ 
subunits [96]. The α subunits appear to have rather similar substrate specificities, but the α2 
isoform is enriched in the nucleus of several cell types, including pancreatic β cells [97], 
neurons [98], and skeletal muscle [99], whereas α1 is predominantly cytoplasmic. The α1 
isoform is associated with the plasma membrane in carotid body type 1 cells [100] and airway 
epithelial cells [101]. The eukaryotic β subunits contain 2 conserved regions, located in the 
central and C-terminal regions. The C-terminal domain is responsible for the formation of a 
functional αβγ complex that is regulated by AMP [102]. The central conserved region is 
recognized to be a glycogen-binding domain, however the functions of this domain remain 
unclear, although it is present in the β subunits of all eukaryotic species [103]. The γ subunits 
(γ1, γ2, and γ3) contain variable N-terminal regions followed by 4 tandem repeats of a 60-aa 
sequence named the CBS motif by Bateman [104]. These act in pairs to form 2 domains (now 
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termed Bateman domains), each of which binds one molecule of AMP, being the regulatory 
binding sites for the nucleotides [105]. The Bateman domains also antagonistically bind ATP 
on a distinct site with a lower affinity than AMP, so that high concentrations of ATP oppose 
activation of the AMPK complex by AMP [106]. 
 
Activation model  
AMP exerts its activation of AMPK by different mechanisms. On the one hand, AMP 
activates AMPK allosterically by binding to the γ subunit. On the other hand, AMP also 
promotes phosphorylation [107] at a specific threonine residue on the α subunit (Thr172) 
[108] by an upstream kinase that has recently been 
identified as a complex between the tumor 
suppressor protein LKB1 and 2 accessory subunits, 
termed STRAD and MO25 [109, 110] (Fig. 20). 
Phosphorylation of Thr172 produces at least 100-
fold activation in contrast to the 5-fold activation of 
the allosteric mechanism. The high increase in 
activation derives from the inhibitory effect of AMP 
on phosphatases that dephosphorylate Thr172 and at 
the same time making AMPK a better substrate for 
LKB1 [109]. The latter mechanism is not acting on 
the LKB1 complex, but only affects AMPK. These 
three effects of AMP make the system very sensitive 
to small increases in AMP. All 3 effects are also 
antagonized by high concentrations of ATP. Note 
that in cells lacking LKB1, such as HeLa cells, there 
is still some basal phosphorylation of Thr172 and AMPK activity [109]. Interestingly, 
phosphorylation of Thr172 as well as AMPK activity can be increased by addition of a Ca2+ 
ionophore. This led to the identification of Ca2+/calmodulin-dependent protein kinase kinase 
(CaMKK) as the responsible kinase for phosphorylation of Thr172 [111-113]. Indeed, Heller 
and colleagues have provided evidence that thrombin, which is acting through a Gq-coupled 
receptor (Gq couples the receptor to phospholipase C which produces inositol-1,4,5-
triphosphate) stimulates AMPK through the Ca2+-mediated pathway [114]. This pathway also 
operates in other cells of the endothelial/hematopoietic lineage, such as T lymphocytes [115]. 
 
 
Figure 20: Activation of AMPK. 
(http://jbiol.com/content/) 
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Regulation of AMPK 
AMPK is an exquisite sensor of the metabolic energy status of the cell. Any metabolic stress 
that inhibits ATP production or that accelerates ATP consumption increases the cellular 
ADP:ATP ration. Consequently, AMPK is activated and can phosphorylate downstream 
targets. Physiological stress that activates AMPK in skeletal muscle is exercise or contraction. 
Upon inhibited oxidative phosphorylation in cells, caused by hypoxia or during pathological 
ischemia, the increased ADP:ATP ratio activates AMPK. This increase was reported in many 
tissues and organs, such as the heart, in pulmonary artery smooth muscle or in glomus cells of 
the carotid body, which sense the oxygen level in arterial blood supplying the brain [100]. 
Most mammalian cells express glucose transporters and hexokinase isoforms that have a very 
low Km for glucose, so that the rate of ATP synthesis from glucose only drops when blood 
glucose falls to pathologically low levels. Accordingly, physiological glucose stress is not 
activating AMPK in these cells. However cells that are specialized for glucose sensing 
express the GLUT2 isoform or hexokinase (hexokinase IV, glucokinase) with a much higher 
Km for glucose, so that the rate of ATP synthesis falls in response to decreases in blood 
glucose within the physiological range. Accordingly, physiological glucose stress is activating 
AMPK in these cells. Thus, in pancreatic β-cells and in neurons of the hypothalamus that 
controls feeding behaviour, AMPK is activated by low glucose levels [116, 117]. 
Accordingly, in lower eukaryotes, where no complex processes such as hormone release and 
feeding behaviour occur, the primary role of the AMPK homolog is the response to glucose 
starvation. The cytokines leptin and adiponectin are both adipokines released from 
adipocytes. These two adipokines are main players in the control of whole body energy 
homeostasis. Leptin, the product of the obese gene (ob), conciliates that fat stores are 
adequate, and exerts a feedback inhibition of food intake via effects on hypothalamic neurons 
which express the leptin receptor [118]. However, as well as inhibiting energy intake, leptin 
also stimulates energy expenditure by promoting uptake and oxidation of glucose [119] and 
fatty acids [120] in skeletal muscle. Leptin can directly activate the α2 subunit of AMPK in 
muscle [121]. The same group showed that leptin inhibited AMPK- α2 activity in the 
hypothalamus of fasted mice. It is known that anorexigenic agents, such as leptin and insulin 
inhibit AMPK- α2 in the paraventricular region of the hypothalamus [122], whereas 
orexigenic agents, such as the gut hormone ghrelin and cannabinoids increase α2 activity in 
the same region in fed mice [123, 124]. AMPK has been reported to be activated by 
adiponectin in skeletal muscle, where it stimulates glucose uptake and fatty acid oxidation and 
in liver, where it inhibits expression of gluconeogenic genes [125, 126]. Liver AMPK, 
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especially the α2 isoform, is necessary for the ability of adiponectin to lower blood glucose 
[127]. 
 
 
 
 
 
Figure 21: Major effects of AMPK activation on glucose and lipid metabolism in liver, muscle, and 
adipose tissue. Effects of AMPK on pyruvate oxidation are mediated by upregulation of mitochondrial 
biogenesis, whereas effects on fatty acid oxidation are mediated by both phosphorylation of ACC2 and 
activation of fatty acid entry into mitochondria, as well as upregulation of mitochondrial biogenesis [5]. 
Metabolic pathways regulated by AMPK 
In general, AMPK switches on catabolic pathways that generate ATP (eg, glucose uptake, 
glycolysis) while switching off ATP-consuming anabolic pathways (fatty acid, cholesterol, 
glycogen, and protein synthesis). Fig. 21 summarizes the major effects of AMPK activation 
on glucose and lipid metabolism in liver, muscle, and adipose tissue, as well as its acute and 
long-term effects on metabolism. It is becoming increasingly clear that AMPK is involved in 
regulating other cellular processes. For example, if cells are running short of ATP, it does not 
make sense for them to grow and proliferate. AMPK inhibits cell growth and proliferation by 
inhibiting both the activity and expression of biosynthetic enzymes involved in lipid, 
carbohydrate, and protein synthesis, and also by switching off the target-of-rapamycin 
(TOR)⇒S6 kinase I pathway [128-130] that appears to be crucial in the regulation of cell 
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growth and cell size. AMPK seems to achieve this by phosphorylation of tuberous sclerosis 
complex-2 (TSC2) (tuberin), an upstream regulator of mTOR [131] (Fig. 22). AMPK 
activation also halts progress through the cell cycle at the G1-S phase transition, which is 
associated with accumulation of the tumor suppressor p53 and of the cyclin-dependent kinase 
inhibitors p21 and p27, which act downstream of p53 [132-134]. Under these conditions, p53 
becomes phosphorylated on Ser15 [134, 135], although it is not clear whether this is a direct 
phosphorylation by AMPK. AMPK activation also has complex effects on apoptosis. In some 
situations, it prevents the process [136-138], whereas in others it induces it [139-142]. 
Successful apoptosis requires ATP, and an explanation for these conflicting findings may be 
that AMPK activation sometimes allows cells to recover from an energy crisis that would 
otherwise have triggered cell death. However, if the cells go past the “point of no return,” 
AMPK may become proapoptotic. AMPK also has a role in cell senescence. Increased 
cellular AMP:ATP and AMPK activity appear to contribute to the senescence observed in 
human fibroblasts after a high number of passages in culture [143]. 
 
Figure 22: Interaction of AMPK and mTOR signaling pathways. (www.icp.ucl.ac.be) 
 
AMPK and IGF-1 signaling pathways  
The insulin/insulin-like growth factor-1 signaling pathway is activated when nutrients are 
available, whereas the AMPK pathway is activated when cells lack a carbon source. Therefore 
these two pathways oppose each other. In mammals, insulin promotes lipid, protein, and 
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glycogen synthesis, whereas AMPK inhibits these biosynthetic pathways. The effect of 
insulin on protein synthesis is mediated in part by activation of the TOR pathway via 
phosphorylation of TSC2, whereas activation of AMPK causes phosphorylation of different 
sites on TSC2 and inhibits TOR [131, 144]. There also appears to be direct crosstalk between 
the two pathways. In some tissues, such as cardiac muscle, insulin antagonizes activation of 
AMPK [145, 146], and this appears to involve activation of the protein kinase Akt [147]. 
Indeed, Akt is able to phosphorylate both AMPKα subunits at a Ser residue, which 
antagonizes AMPK activation via phosphorylation at Thr172 [148]. In other cases, the insulin 
and AMPK signaling pathways work in the same direction, particularly in processes that 
regulate plasma glucose levels. In skeletal muscle, both insulin and AMPK activation 
stimulate glucose uptake by increased translocation of GLUT4 to the plasma membrane, 
although the subsequent fate of the glucose is different (glycogen synthesis in the case of 
insulin, which is anabolic; glycolysis/oxidation in the case of AMPK, which is catabolic). The 
two pathways appear to converge on the phosphorylation of AS160 [149, 150], a protein with 
a Rab-GTPase–activating protein (Rab-GAP) domain that is involved in regulation of GLUT4 
translocation. Activation of AMPK plays a major part in the well-known ability of muscle 
contraction to stimulate glucose uptake. AMPK activation may also be involved in the effects 
of repeated exercise (ie, training) to improve insulin-sensitive glucose uptake, because of its 
ability to increase expression of GLUT4 [151] and perhaps other effects. A second case in 
which insulin and AMPK act in the same direction occurs in the liver, in which both proteins 
repress the expression of enzymes involved in gluconeogenesis, such as phosphoenolpyruvate 
carboxykinase and glucose-6-phosphatase [152]. It makes sense that insulin, a hormone 
released in response to high blood glucose, should repress hepatic glucose production, 
whereas in the case of AMPK it may have evolved because of its catabolic actions. Gene 
repression by AMPK is thought to occur via phosphorylation and consequent cytoplasmic 
sequestration of the transcriptional coactivator TORC2 [153]. Repression of gluconeogenesis 
appears to be the major cause of the plasma glucose-lowering effects of the adipokine 
adiponectin and the antidiabetic drug metformin on plasma glucose levels. In both cases, there 
is evidence that the mechanism involves activation of AMPK [125, 154]. A final case in 
which insulin and AMPK act in the same direction occurs in adipocytes, where insulin and 
AMPK suppress activation of hormone-sensitive lipase, and hence lipolysis, by cAMP 
elevating agonists [106, 155, 156]. While insulin causes phosphorylation and activation of 
phosphodiesterase 3B by Akt to lower cAMP [157], AMPK phosphorylates hormone-
sensitive lipase at a site (Ser565) that antagonizes activation by cAMP-dependent protein 
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kinase [158]. This makes sense regarding the anabolic actions of insulin, but the reason why 
AMPK should suppress lipolysis requires explanation. If fatty acids released by lipolysis are 
not removed from the cell rapidly enough, they are known to recycle into triglyceride, thus 
consuming ATP. Inhibition of lipolysis by AMPK has been proposed as a mechanism to limit 
this recycling, ensuring that the rate of lipolysis does not exceed the rate at which fatty acids 
can be removed or metabolized by other routes, such as fatty acid oxidation [159]. 
 
 
Figure 23: Roles of AMPK in the control of whole-body energy metabolism [3]. 
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ABSTRACT 
PASKIN is a PAS domain serine/threonine AMP-related sensory kinase which is 
ubiquitously expressed at low levels with highest expression in the testis. We recently 
generated PASKIN knock-out mice which did not show any obvious phenotype. Yeast 
data suggest that PASKIN is involved in energy homeostasis. Thus, PASKIN might sense 
the altered concentration of a (unknown) metabolic ligand which triggers the interaction 
and / or phosphorylation of target proteins such as glycogen synthase. We found that 
Paskin-/- mice are protected from weight gain and triglyceride increases when fed with a 
high fat diet. Glucose tolerance was not impaired under high fat diet conditions. These 
effects might be attributed to the increased activity of AMPK because there was more 
phospho-AMPK present in skeletal muscle tissue of PASKIN than wild type mice. These 
data suggest that PASKIN might be an antagonist of AMPK and contributes to 
balancing energy homeostasis by AMPK. We detected a decreased spontaneous activity 
of Paskin-/- mice and assume that PASKIN is implicated in AMPK-dependent energy 
homeostasis of skeletal muscle. 
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INTRODUCTION 
PAS (Per-Arnt-Sim) proteins are known from all three kingdoms of life where they represent 
protein sensors involved in the perception of light intensity, oxygen partial pressure, redox 
potentials, voltage and certain ligands [9] [10] [19]. The mammalian PAS domain-containing 
proteins can also serve as heterodimerization interfaces of transcription factors involved in the 
xenobiotic response, adaptation to hypoxia and circadian rhythm generation [12] [13] [12, 
160]. By database searches using the PAS sequence as a bait, we and others identified a novel 
mammalian PAS protein termed PASKIN [4] or PASK [17]. PASKIN contains two PAS 
domains showing a high sequence similarity to the oxygen sensor protein FixL of Rhizobium 
species, and a serine/threonine kinase domain related to AMP-kinases. As known from FixL, 
the PAS domain represses the kinase activity in cis. Upon ligand-binding to the PAS domain, 
the kinase domain is activated in trans, resulting in auto-phosphorylation of the kinase 
domain [17]. Ligand binding as well as mutation of the PAS A domain result in activation of 
the kinase domain. Synthetic ligands were identified and show a structural similarity to 
dioxin, known to bind to the PAS domain of the aryl hydrocarbon receptor [2]. However, an 
endogenous ligand for PASKIN activation has not been identified so far. 
To elucidate the function of PASKIN, our lab previously generated PASKIN deficient knock-
out mice. Surprisingly, PASKIN is highly upregulated in the testis during the post-meiotic 
stages of spermatogenesis. PASKIN mRNA expression is remarkably higher in the testis than 
in all other tissues. However, neither male fertility nor sperm production or motility was 
affected in PASKIN knock-out mice [29]. 
From the yeast PASKIN homologs PSK1 and PSK2 we know that the psk1 psk2 double-
mutant strain shows a decreased growth at elevated temperature (39°C) and galactose supply. 
PSK1 and PSK2 phosphorylate three translation factors (Caf20, Tif11 and Sro9) and two 
enzymes involved in glycogen and trehalose synthesis (Ugp1, Gsy2), thus controlling 
translation and sugar flux [1]. Recently, it has been shown that the mammalian glycogen 
synthase interacts with the midregion of human PASKIN and is phosphorylated at Ser-640 
[38].  
AMPK is a well-conserved serine/threonine protein kinase that has been proposed to act as a 
cellular fuel gauge [161]. It is formed by a catalytic subunit (α) and two regulatory subunits (β 
and γ). Each subunit exists as multiple isoforms (α1, α2, β1, β2, γ1, γ2 and γ3), each encoded 
by a different gene [162]. AMPK is activated allosterically by an increase in the intracellular 
AMP/ATP ratio and also by phosphorylation of the threonine 172 residue, a residue located in 
 65
PASKIN FUNCTION IN ENERGY HOMEOSTASIS 
_________________________________________________________________________________________________________________ 
 
the activation loop of the α subunit [159]. Once activated, AMPK leads to a concomitant 
inhibition of energy-consuming biosynthetic pathways and activation of ATP-producing 
catabolic pathways. 
In this work we show that PASKIN is to some extent a direct counterplayer of the AMPK 
signaling pathway. When the diet was changed from 5% to 45% fat, Paskin-/- mice resisted to 
fat accumulation and glucose intolerance. Significantly decreased spontaneous activity of 
Paskin-/- mice led us to focus on the involvement of PASKIN in AMPK signaling of skeletal 
muscle. 
 
 
Methods 
Primary cells and culture conditions 
MEFs were prepared from 13.5-day-old Paskin-/- and Paskin+/+ embryos. Following removal 
of the head and inner organs, embryos were rinsed with ice cold phosphate-buffered saline 
(PBS) and 2% FCS, minced, and digested with trypsin (0.05% solution containing 0.53 mM 
EDTA) for 15 min at 37°C, using 2 ml per embryo. Cells were resuspended before and after 
addition of 5 ml MEF media (DMEM, 10% FCS, 1% glutamine, 100 IU/ml penicillin, 100 
μg/ml streptomycin, 200 μM β-mercaptoethanol). The resulting suspension from one single 
embryo was plated into one 10 cm diameter culture dish and incubated at 37°C and supplied 
with in a 5% CO2 humidified chamber.  Cells were grown 2 days, until the culture was 90% 
confluent, split once, harvested, frozen, and labeled as passage 1. 
 
Cell culture and transient transfection 
HEK293 embryonic kidney carcinoma cell lines were cultured in high-glucose Dulbecco’s 
modified Eagle’s medium (DMEM) (Sigma) as described previously [163]. Transient 
transfections were performed with the polyethylenimine (Polysciences) method [164]. 
 
Animals 
Paskin-/- mice [29] were backcrossed into C57BL/6J (The Jackson Laboratory) for 10 
generations. C57BL/6J animals were raised in the same room under the same conditions. 
Mice were maintained on a normal chow diet (4.5% fat, KLIBA NAFAG) or a high fat diet 
(45% fat, Research Diets) beginning at 12 weeks of age. In each experiment, age-matched 
wild type mice were used as controls. All animal handling followed the guidelines for the use 
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and care of laboratory animals of the Bundesamt für Veterinärwesen and was approved by the 
Kantonales Veterinäramt Zürich (Nr. 192/2003). 
 
Immunoblotting 
Total protein extracts of cultured cells were prepared using cell lysis buffer (10 mM Tris-HCl 
pH 8.0, 1 mM EDTA, 400 mM NaCl, 0.1% NP-40, protease inhibitor cocktail (Roche)). 
Following incubation on ice for 5-10 min, the lysate was centrifuged (5 min / 15´000 rpm / 
4°C) and the supernatant stored at -80°C. Protein concentrations were determined by the 
Bradford method using bovine serum albumin as a standard [62]. For immunoblot analysis, 
cellular protein was electrophoresed through SDS-polyacrylamide gels and electrotransferred 
onto nitrocellulose membranes (Schleicher & Schuell) by semi-dry blotting. Membranes were 
stained with Ponceau S (Sigma) to confirm equal protein loading and transfer. All washing 
steps were performed with Tris buffered saline (TBS) containing 0.1% Tween-20. 
Membranes were incubated for 2 h in blocking buffer (0.1% Tween-20 with 5% w/v nonfat 
dry milk in TBS). The following antibodies were used for incubation in primary antibody 
dilution buffer (0.1% Tween-20 with 5% BSA in TBS): rabbit monoclonal antibody (mAb) 
anti-AMPKα (Cell Signaling) and rabbit mAb anti-phospho-AMPKα (Cell Signaling); rabbit 
polyclonal anti-β-actin (Sigma); and secondary polyclonal goat anti-mouse or anti-rabbit 
antibodies coupled to horseradish peroxidase (Pierce, Perbio, Lausanne, Switzerland). 
Chemiluminescence detection was performed with the Supersignal West Dura kit (Pierce) and 
chemiluminescence was recorded with a CCD camera (FluorChem8900, AlphaInnotech, 
Witec, Littau, Switzerland) or by exposure to X-ray films (Fuji, Düsseldorf, Germany) 
 
Running wheel 
A flexible computer-controlled running wheel system (TSE Systems International Group) was 
used to detect spontaneous activity with following dimensions for use with mice: drum 
diameter: 115 mm, drum depth: 40 mm, drum rods: 4 mm diameter and 5 mm distance 
between two rods. In total, 16 Paskin-/- and 16 Paskin+/+ mice at the age of 16 weeks (8 males 
and 8 females) were measured during a time period of two weeks. Animals got adapted to the 
new environment for 2 days. 
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Glucose / insulin tolerance test in vivo 
Glucose tolerance test (GTT) - animals were fasted 16 h, after which 20% glucose in 0.9% 
NaCl (2 g glucose/kg body weight) was injected intraperitoneally. At the indicated times, tail 
vein blood was sampled for glucose determination by electrochemical measurements (Accu-
Chek Aviva, Roche Diagnostics). When performing GTT the animals were 9 months old and 
the HFD group was on HFD for 6 months. 
Insulin tolerance test (ITT) - human recombinant insulin (0.75 U/kg body weight) was 
intraperitoneally injected to fasted mice (16 h) and blood glucose levels were determined at 
the indicated times. When performing ITT the animals were 10 months old and the HFD 
group was on HFD for 7 months. 
 
Indirect calorimetry 
Measurements were performed in an open circuit calorimetry system (AccuScan Inc., 
Columbus, OH). Room air was passed through each cage with a flow rate controlled at 
approximately 2 l/min. Every 2 min, out-coming air was sampled during 20 s for each 
individual cage and analyzed for V(O2) (ml / kg / min) and V(CO2) (ml / kg / min). 
Simultaneously, physical activity was monitored by 3 arrays of 16 infrared light beam 
sensors. Furthermore, food intake and water intake were measured continuously. All data 
were analyzed with AccuScan Integra ME software. Energy expenditure was calculated for 
each 2 min sample according to Weir [165] using the following equation: total energy 
expenditure (kcal/h) = 3.9 × V(O2) ml/h + 1.1 × V(CO2) ml/h. The average over 60 min was 
calculated for each individual animal and expressed as kcal/h. The respiratory quotient (RQ) 
is defined as the quotient between CO2 production and O2 consumption. The light beam 
breaks were converted into distance travelled in centimeter. In the first measurement the 
Paskin-/- and Paskin+/+ mice were all on NCD and were at the age of 12 weeks. Subsequent 
switch of one group to HFD and further two measurements after 6 and 12 weeks on HFD, 
respectively, were performed. 
 
Blood analysis 
Paskin-/- and Paskin+/+ mice were 11 months old and one group had been fed HFD for the last 
8 months. Animals were fasted for 6 hours before anaesthesia (200 mg/kg ketamine, 10 mg/kg 
xylazine). Up to 1 ml blood was removed from the portal vein into a 1 ml heparin rinsed 
syringe using a 25 G needle. After centrifugation (5 min / 8000 g / 25°C) the plasma was 
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collected and frozen at -80°C. Measurements of indicated analytes were performed by the 
Institute for Clinical Chemistry (IKC, USZ Zürich). 
 
 
Results 
Body weight of Paskin-/- and Paskin+/+ mice 
First, we backcrossed Paskin-/- mice for 10 generations to have a genetically homogenous 
C57BL/6 background. Then we weighed 
the Paskin-/- and C57/BL6 wild-type mice 
on a daily base from day 6 on and after 
weaning on a weekly base until the age of 
three months. The graphs in Fig. 1 
represent the mean weight of indicated 
numbers of animals at an age of 65 days. 
Male but not female Paskin-/- mice were 
significantly heavier with p < 0.05 as 
calculated by an unpaired t-test. 
 
Figure 1: Body weight of Paskin+/+ and Paskin-/- mice. 
The body weight at the age of 65 days is shown for the 
indicated numbers of animals. Data are expressed as 
mean values±SEM. 
 
Running wheel performance of Paskin-/- and Paskin+/+ mice 
We next examined the spontaneous running wheel activity of Paskin-/- and Paskin+/+ mice. 
The fact that male Paskin-/- mice are slightly heavier might be caused by a lower spontaneous 
activity. We let the animals accommodate for one week in the new cage containing the 
running wheels. We then measured the running distance during 14 subsequent days. As 
expected, the animals did not run during the light phase, therefore the run distance in the dark 
phase is shown. The average distance ran during these 13 nights was calculated per animal. 
The mean values of eight animals for each group are shown in Fig. 2a. Sex is a significant 
factor in daily running wheel activity, with female mice known to run an average of 20% 
farther and 38% faster than male mice [166]. One reason might be that in cycling female mice 
the second part of the proestrus night is often characterized by increased motor activity (over 
100%) compared to the remaining estrus cycle nights [167]. Surprisingly we found that 
Paskin-/- animals ran significantly shorter distances during the night when compared with 
Paskin+/+ mice. This behavior is even more pronounced for male mice (p<0.01) than for 
female mice (p<0.05). When analyzing the data in more detail we found various animals 
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which suddenly stopped running without any obvious reason and suddenly started using the 
running wheel again after a couple of nights or alternatively did not enter the wheels anymore. 
Therefore, Fig. 2b shows the same experiment as in Fig. 2a, but only representing mice which 
used the wheel every night. This led to a smaller number in animals and the mean values for 
the distances ran per night per animal were calculated only from 6 nights and 7 nights for 
female and male animals, respectively. Female (p< 0.05) and male (p<0.05) Paskin-/- animals 
still ran significantly less than Paskin+/+ animals. The measurement resolution in the running 
wheel experiment is 2 h, meaning that the wheel rotations during the 2 h are added to one 
value. With our running wheels, the raw data do not provide detailed information about the 
behavior of the animals in the running wheel when compared to systems that use a resolution 
of 1 minute. Nevertheless, all raw data points derived from Paskin-/- animals are smaller when 
compared to Paskin+/+ animals. 
 
 
 
Figure 2: Running wheel distance of Paskin-/- and Paskin+/+ mice. (a) Average distance run during 14 
subsequent dark phases of 8 animals per group. (b) The same experiment as in (a) but animals which were 
not active every night during the measured period of time were removed from statistics. 
AMPK expression in Paskin-/- and Paskin+/+ mouse embryonic fibroblasts 
We generated mouse embryonic fibroblast (MEF) from our Paskin-/- and Paskin+/+ mice to 
examine whether PASKIN might have an effect on AMPK, the sensor of the metabolic 
energy status of the cell. We kept primary MEFs in culture until cells spontaneously 
immortalized. Immunoblots were performed with primary MEFs and with MEFs that 
spontaneously immortalized. Lower protein levels of phospho-AMPK were detected in 
primary Paskin+/+ MEFs. No changes in AMPK protein levels were visible with immortalized 
MEFs (data not shown). It is possible, that this discrepancy in the protein levels of AMPK 
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derives from a clonal artefact which possibly was induced by the spontaneous 
immortalization. Phosphorylation of AMPK was almost absent in spontaneously immortalized 
Paskin+/+ MEF when compared to Paskin-/- MEF (Fig. 3). By quantitative RT-PCR to detect 
AMPK mRNA levels in Paskin-/- and Paskin+/+ MEFs, the presence of AMPK subunit α1 and 
not AMPK subunit α2 in these cells was shown. Furthermore we could confirm in both the 
spontaneously immortalized and the primary MEFs that a possible regulation of AMPK 
through PASKIN does not occur on the mRNA level (data not shown). 
 
 
Figure 3: P-AMPKα detection in glucose stimulated Paskin-/- and Paskin+/+ MEFs. Before glucose 
stimulation, MEFs were starved in medium containing 1.6 mM glucose for 30 minutes, medium was 
exchanged and the MEFs incubated for another hour in 1.6 mM glucose. The medium was replaced by fresh 
medium containing 0 mM, 1.6 mM, 16.7 mM, 25 mM or 33.3 mM glucose and the MEFs were incubated for 
24 hours at 37°C. Additionally, lysates from non-stimulated MEFs in DMEM supplied with 25 mM glucose 
were loaded. (WTMEF-E2.8 p.14: Paskin+/+ MEF from embryo number 2.8 after 14 passages, PMEF-E-3.1 
p.14: Paskin-/- MEF from embryo number 3.1 after 14 passages) 
To further investigate AMPK protein levels and phosphorylation in PASKIN deficient cells, 
we transiently transfected HEK293 with 4 different shRNA plasmids (pLKO.1-puro). The 
transient transfection of HEK293 did not down-regulate PASKIN protein levels (Fig. 4). 
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Figure 4: Transiently transfected HEK293. HEK293 cells were transfected with 4 different PASKIN shRNA 
pLKO.1-puro plasmids (905, 1271, 3275, 4207) and protein were extracted after 42 hours. Lysates of Sf9 cells 
transfected with a plasmid containing His-tagged PASKIN were used as positive controls in a dilution series for 
PASKIN expression. 
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Effect of high fat diet on body weight of Paskin-/- and Paskin+/+ mice 
To challenge metabolic homeostasis, we fed Paskin-/- and Paskin+/+ mice with a diet 
consisting of 45% fat versus 4.5% fat supplied in the normal chow diet (NCD). At the age of 
14 weeks, 16 Paskin-/- mice (8 female and 8 male) were fed either high fat diet (HFD) or 
NCD. Analogously, 16 Paskin+/+ control animals were included. Food uptake of each mouse 
was measured three times per week. The animals were weighed once per week. The left panel 
of Fig. 5 represents the body weight, the cumulative body weight increase and the cumulative 
food uptake under NCD, while on the right panel the same evaluation is illustrated under HFD 
condition. Male Paskin-/- mice showed significantly increased body weight under NCD when 
compared to male Paskin+/+ mice (two tailed unpaired t-test, p<0.0001) while the cumulative 
body weight gain did not significantly differ between Paskin+/+ and Paskin-/- mice . Food 
intake was linear and implicates that the male animals ate equal amounts of NCD. 
Interestingly, under HFD the body weight of male Paskin-/- mice increased less than male 
Paskin+/+ mice fed HFD. Female Paskin-/- mice fed NCD have increased body weight 
compared to female Paskin+/+ mice (two-tailed unpaired t-test, p<0.005) (Fig. 6). When fed 
HFD female Paskin+/+ mice significantly gain more body weight (two-tailed unpaired t-test, 
p<0.05) than female Paskin-/- mice (Fig. 6). Comparably, the body weight gain is increased in 
female Paskin+/+ mice, while the food intake is identical between female Paskin+/+ and 
Paskin-/- mice (Fig. 6). 
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Figure 5: Male Paskin-/- and Paskin+/+ body weight, cumulative body weight gain and cumulative food 
intake. Male Paskin-/- (n=8) and male Paskin+/+ (n=8) mice were fed NCD (left panel) or HFD (right panel) 
starting at the age of 12 weeks. Body weight measurements were performed on a weekly base for 14 weeks. 
During the same period, for each mouse food intake was measured 3 times per week. Data are expressed as 
mean±SEM per week. 
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Figure 6: Female Paskin-/- and female Paskin+/+ body weight, cumulative body weight gain and 
cumulative food intake. Female Paskin-/- (n=8) and female Paskin+/+ (n=8) mice were fed NCD (left panel) 
or HFD (right panel) starting at the age of 12 weeks. Body weight measurements were performed on a 
weekly base for 12 weeks. During the same period, for each mouse food intake was measured 3 times per 
week. Data are expressed as mean±SEM per week. 
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Intraperitoneal glucose tolerance tests with HFD fed mice  
Feeding of HFD results in impaired overall glucose homeostasis and is finally leading to the 
metabolic syndrome [168]. To asses whether Paskin-/- mice are prone to diabetes, 
intraperitoneal (i.p.) glucose tolerance tests (IPGTT) were performed, in which plasma 
glucose levels were monitored over time following i.p. glucose injection. Note that under 
NCD the ability to clear glucose was not obviously different between Paskin+/+ and Paskin-/- 
mice [7]. The left panel of Fig. 7 represents the results of IPGTT under NCD for male mice 
(top) and female mice (bottom). As shown before, there were no differences in glucose 
clearance, either in female or in male NCD-fed mice. However, HFD-fed Paskin-/- males 
(right panel) showed significantly better glucose clearance relative to Paskin+/+ males. 
Surprisingly this phenotype could not be confirmed with Paskin-/- females (Fig. 7). 
 
Figure 7: Intraperitoneal glucose tolerance tests in Paskin+/+ and Paskin-/- male and female mice fed 
NCD or HFD. Mice were fasted for 16 hours before i.p. administration of 2 g/kg body weight D-glucose. 
Blood glucose was measured every 30 minutes. Left panel: IPGTT in mice fed NCD (male Paskin+/+, n=3; 
male Paskin-/-, n=3; female Paskin+/+, n=3; female Paskin-/-, n=4), right panel: IPGTT in mice fed HFD for 
7 months (male Paskin+/+, n=4; male Paskin-/-, n=4; female Paskin+/+, n=3; female Paskin-/-, n=3). All 
animals were 9 months old, when IPGTT was performed. Data are expressed as mean ± SEM. * = p < 0.05, 
** = p < 0.01 (two-tailed unpaired t-test). 
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Insulin tolerance tests were performed with the same animals one week later. The animals did 
not respond accurately to the i.p. administered 0.75 U insulin per kg of body weight. 
Especially male animals hardly lowered their blood glucose levels independent of their 
genotype. Female mice showed a drop of 40 mg/dl, however the fasted blood glucose level 
was already low in NCD animals (80 mg/dl). We saw a significant lower blood glucose level 
in fasted male Paskin-/- mice when compared to Paskin+/+ males. 
 
 
Figure 8: Intraperitoneal insulin tolerance tests in Paskin+/+ and Paskin-/- male and 
female mice fed NCD or HFD. Mice were fasted for 16 hours before i.p. administration 
of 0.75 U/kg body weight insulin. Blood glucose was measured every 15 minutes. Left 
panel: IPITT in mice fed NCD (male Paskin+/+, n=3; male Paskin-/-, n=3; female 
Paskin+/+, n=3; female Paskin-/-, n=4), right panel: IPITT in mice fed HFD for 7 months 
(male Paskin+/+, n=4; male Paskin-/-, n=4; female Paskin+/+, n=3; female Paskin-/-, n=3). 
All animals were 10 months old, when IPITT was performed. Data are expressed as 
mean±SEM. * = p < 0.05 (two-tailed unpaired t-test).
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Indirect calorimetry measurements with Paskin-/- and Paskin+/+ mice 
HFD leads to obesity and other metabolic syndrome related diseases [168]. Obesity occurs 
from an inbalance between energy intake (food intake) and energy expenditure (basal 
metabolism and physical activity) [169]. Paskin-/- animals are partially resistant to body 
weight increase and impaired glucose clearing upon HFD. Under NCD, though, they show a 
lower running wheel activity compared with Paskin+/+ mice. To further elucidate a possible 
connection between these two phenotypes, we measured food intake, water intake, locomotor 
activity, O2 consumption and CO2 emission by indirect calorimetry using metabolic cages. 
From these data energy expenditure and respiratory quotient (RQ) were calculated. The 
animals got adapted for 24 hours to the new cages before measurements were started. The 
whole experiment lasted 24 hours, while during the active phase (12 h) food was given ad 
libitum and during the inactive (12 h) phase food was not available. In total 32 animals were 
measured (16 Paskin+/+ mice and 16 Paskin-/- mice). Each group consisted of 8 female and 8 
male animals, while 4 of each gender received HFD. The first measurement was performed 
before the administration of HFD to obtain basal values. Two subsequent measurements were 
performed after 6 and 12 weeks of HFD feeding, respectively. No differences at all in energy 
expenditure, oxygen consumption or water intake were detected between Paskin+/+ mice and 
Paskin-/- mice (data not shown, two-tailed unpaired t-test). No significant differences were 
found in locomoter activity, food intake or the respiratory quotient (data not shown, two-
tailed unpaired t-test).  
 
Blood plasma analysis of Paskin-/- and Paskin+/+ mice 
After the experiments in the metabolic cage were completed, blood was collected. Because 
these parameters have never been determined in these mice so far, various electrolytes, 
including sodium, potassium, chloride, total calcium and phosphate were estimated. Moreover 
urea, uric acid and creatinine were measured, which reflect proper kidney function, and 
creatin kinase, representing heart and muscle performance, were determined. Further marker 
enzymes were measured to detect proper liver function like alanin-aminotransferase (ALT), 
aspartate-aminotransferase (AST) and the activity of alkaline phosphatase, as marker for liver 
function and skeletal muscle performance was measured. Markers for the lipid homeostasis 
like cholesterol and triglyceride were estimated. Alkaline phosphatase activity was 
significantly increased in Paskin-/- males when fed NCD (Fig. 9a). However the values for the 
females were unchanged between Paskin-/- and Paskin+/+ mice. Total cholesterol blood levels 
are expected to be elevated under HFD [170]. This was true for Paskin+/+ female mice (Fig. 
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9b). Paskin-/- females, however, had less cholesterol in their blood which is consistent with 
the finding that under high fat diet their body weight was not elevated to the same extent as 
the Paskin+/+ body weight. However, for male animals the contrary was found leading to very 
moderate effects when male and female values were taken together (Fig. 9b). High 
triglyceride blood levels arise as a consequence of secondary hyperlipemia and are associated 
with diabetes mellitus [171]. Although not significant, triglyceride levels were elevated in 
HFD fed male Paskin+/+ animals when compared to Paskin-/- male mice. The contrary was 
true for female animals (Fig. 9c). We detected increased free fatty acid levels in HFD and 
NCD Paskin-/- females versus Paskin+/+ females (Fig. 9d). In Fig 10 other blood metabolites 
are taken together. No significant differences could be detected. 
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Figure 9: Alkaline phosphatase activity and Lipid homeostasis in Paskin+/+ and Paskin-/- male and 
female mice under NCD and HFD. Mice were fasted for 6 h before blood was taken from the portal vein. 
Data are expressed as mean±SEM. * = p < 0.05 (two-tailed unpaired t-test). 
 
 
 
 79
PASKIN FUNCTION IN ENERGY HOMEOSTASIS 
_________________________________________________________________________________________________________________ 
 
 80
 
Figure 10: Electrolytes, kidney parameters, total protein, liver enzymes, muscle enzymes and glucose in Paskin+/+ 
and Paskin-/- male mice under NCD and HFD. Mice were fasted for 6 h before blood was taken from the portal vein. 
Data are expressed as mean±SEM. * = p < 0.05 (two-tailed unpaired t-test). 
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DISCUSSION 
When fed a high-fat diet (HFD), C57BL/6J mice are known to develop obesity and a number 
of symptoms reminiscent of the metabolic syndrome, including insulin resistance [168]. 
Unpublished data from Rutter´s group suggest that PASKIN is an inhibitor of AMPK 
expression and therefore acts as a regulator of energy homeostasis [172]. Rutter´s main 
preliminary finding is that Paskin-/- mice are protected from the effects of a HFD, and he 
suggested that this phenotype originates from increased AMPK expression and activity in 
Paskin-/- mice. We could confirm that under HFD female Paskin-/- mice gain significantly less 
body weight when compared to Paskin+/+ mice. The same observations were made for male 
mice, but data were not significant. Importantly, this retention in body weight gain under 
HFD does not arise because of different feeding behaviour. Furthermore, male Paskin-/- mice 
under NCD are significantly heavier than Paskin+/+ mice, consistent with the decreased 
running activity of Paskin-/- mice. 
Concerning AMPK protein levels and activity we could so far see stronger protein 
phosphorylation of AMPKα in MEFs derived from Paskin-/- mice than in Paskin+/+ MEFs. 
Most probably due to clonal differences in our Paskin-/- and Paskin+/+ MEFs, we did not 
detect elevated AMPKα protein levels in Paskin-/- MEF. Rutter and colleagues did not 
measure AMPKα protein level or phosphorylation in MEFs but found AMPKα protein levels 
elevated in Paskin-/- gastrocnemius muscle, soleus muscle and in pancreatic islets. 
Furthermore they found AMPKα protein levels and phosphorylation to be elevated in liver 
extracts of Paskin-/- [172]. In order to elucidate the effect PASKIN might have on AMPKα 
we are in the process of generating stable Paskin-/- HEK293 shRNA-mediated knock-down 
cell lines. 
Rutter et al. found triglyceride accumulation in liver of male mice only for the control wild-
type animals on high-fat diet and the fat mass was accordingly decreased in the knock-out 
animals compared to the control animals [172]. By blood analysis we did not find 
significantly increased triglyceride levels. Therefore, more animals need to be analyzed for 
triglyceride levels in the blood, since in male Paskin+/+ when compared with Paskin-/- the 
higher triglyceride levels might become significantly higher with representative numbers of 
animals measured. Moreover a gender specific effect could then either be confirmed or 
disproved, as in females we did not measure a difference in triglyceride levels. The decreased 
body weight in Paskin-/- mice might originate from a decreased fat mass [172], therefore a 
lower triglyceride level would represent a convenient explanation why the body weight of 
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Paskin-/- mice is lower under HFD. Measurement of free fatty acid is error-prone due to high 
autohydrolysis of lipids and strongly depends on the fasted state. It might be that 6 hours 
fasting is too short for adequate free fatty acid determination. 
As obesity results from the imbalance between energy intake and energy expenditure, 
metabolic chambers were used to examine the mechanisms that are partially protecting 
Paskin-/- mice from obesity. Rutter et al. found Paskin-/- mice to consume more oxygen, to 
emit more carbon dioxide and to generate more heat during the day and the night [172]. 
Rutter et al. confirmed this hypermetabolic phenotype by the finding that the ATP production 
rate was higher in Paskin-/- than in Paskin+/+ soleus muscle fibres. However neither increased 
mitochondrial number, mitochondrial mass, nor citrate synthase activity accounted for this 
difference. A discrepancy was encountered with our experiments where we applied indirect 
calorimetry to Paskin+/+ and Paskin-/- mice. We did not find any hypermetabolic phenotype in 
Paskin-/- mice. This could be explained by the finding that the animals did not get used to the 
metabolic chambers during the 24 h adaptation time. Hence, a longer adaptation time is 
needed. A recent publication shows that rats are being adapted for two weeks to the metabolic 
cages before measurements were started [173]. The mice were scared and therefore lost 
weight in these metabolic cages. This weight loss can be seen in Fig. 5 and Fig. 6, 
respectively. Surprisingly Rutter et al. allowed the animals to adapt only for 4 hours to the 
new surrounding, although measurements went on for 3 days. Rutter et al. used only 3 male 
animals for this setup while we performed indirect calorimetry with 32 animals. 
Since diet-induced obesity is accompanied by increased triglyceride accumulation in 
peripheral tissues and strongly associates with the development of insulin resistance, glucose 
and insulin tolerance tests were performed. Rutter et al. found lower basal insulin levels in 
Paskin-/- mice already under NCD. The fasted insulin levels of HFD-fed Paskin-/- mice were 
half the value of wild-type mice [172]. Under HFD Paskin-/- animals showed better glucose 
tolerance and increased insulin sensitivity compared to Paskin+/+ animals [172]. We detected 
increased glucose tolerance in HFD-fed Paskin-/- male as well, since they cleared glucose 
significantly faster than the control animals. Surprisingly in females we could not confirm 
these findings. Rutter et al. performed IPITT on fed animals and saw increased insulin 
sensitivity in male Paskin-/- mice [172]. We did not find increased insulin sensitivity in 
Paskin-/- mice. However, it could be that the advanced age of our animals was responsible for 
the lack of an adequate insulin response. 
S6 Kinase 1 (S6K1) deficient mice are hypoinsulinaemic, glucose intolerant and have a 
reduced β-cell mass, although their glucose levels are normal [174]. Thus Um et al. suggest a 
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hypersensitivity to insulin owing to the apparent loss of a negative feedback loop from S6K1 
to insulin receptor substrate (IRS1). Since PASKIN mice show reduced insulin levels [172] 
and do show an increased insulin sensitivity under HFD [172] the S6K1 might be involved in 
the energy metabolism of PASKIN mice. Furthermore when fed HFD mice are known to 
increase S6K1 acitvity, therefore negatively regulating insulin signalling[174]. Thus levels of 
S6K1 need to be addressed in our PASKIN mice for further understanding the pathways 
leading to a obesity suppressed phenotype. 
It will be important to examine whether the detected decreased running wheel activity of 
Paskin-/- mice is due to an inability of long lasting work affected by muscle dystrophy, or 
whether Paskin-/- mice have defects in the peripheral and / or central nervous system. To 
understand this behaviour, circadian rhythm experiments coupled with running wheel activity 
are currently being performed with 11 Paskin-/- and 11 Paskin+/+ male mice. A special role for 
PASKIN in skeletal muscle in correlation with AMPK might be an explanation for the 
demonstrated phenotype. 
 
 
7.3 Conclusions 
We found that PASKIN deletion suppresses phenotypes associated with a high-fat diet. This 
is supported by the finding that Paskin-/- mice were partially protected from obesity when 
high-fat diet was fed. Furthermore lower triglyceride plasma levels and better glucose 
clearance point towards a role of PASKIN in whole body energy metabolism. These 
phenotypes suggest that AMPK signaling might be suppressed to some extent by PASKIN. 
Fujii et al. [175] recently examined muscle AMPK in maximal exercise capacity. In 
transgenic mice carrying cDNAs of inactive AMPK α2, the maximal exercise capacity was 
dramatically reduced and a faster decrease of muscle glycogen by in situ muscle contraction 
was measured. If PASKIN inhibits AMPK activity, our Paskin-/- mice should perform better 
in a maximal exercise test. On the other hand we know from the yeast homologs that 
glycogen accumulation is inhibited by active PASKIN. Therefore the decreased spontaneous 
activity of Paskin-/- mice needs further examination. It is necessary to perform exercise 
tolerance tests with Paskin-/- mice or to perform muscle contraction experiments in vitro to see 
whether the phenotype of decreased spontaneous activity has its origin in muscle function or 
whether the CNS is responsible for this phenotype. 
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Intriguingly, in at least 3 animal models that are resistant to diet-induced obesity, ie, mice 
overexpressing the uncoupling proteins UCP1141 or UCP3, [176] or mice with a knockout of 
stearoyl- CoA desaturase-1 [177], a persistent activation of AMPK in the affected cell types 
appears. The ability of AMPK to inhibit adipocyte lipolysis and to stimulate fatty acid 
oxidation in many tissues, both acutely via phosphorylation of ACC2 [178] and chronically 
by up regulating peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) 
and mitochondrial biogenesis, [179, 180] is also likely to be beneficial in insulin resistance 
and type 2 diabetes. There is much evidence that these conditions are partly caused by 
abnormal accumulation of triglyceride in muscle and liver and that this can be at least partly 
caused by a defect in mitochondrial function [181]. Interestingly, incubation of cultured cells 
with high levels of the saturated fatty acid palmitate affected the integrity of the endoplasmic 
reticulum and led to cell death, and this was ameliorated using 5-amino-4-
imidazolecarboxamide riboside (AICAR) an AMP analogue to activate AMPK and stimulate 
fatty acid oxidation [182]. One objection is that it has also been proposed that high rates of 
fatty acid oxidation can be damaging because of oxidative stress, for example, in ischemic 
heart following reperfusion [183] and in endothelial cells [184]. It will be important to 
establish whether any adverse effects of AMPK activation in certain cell types are 
compensated by the overall improvements in metabolic status. PASKIN might be implicated 
to keep this balance and to protect from oxidative stress and therefore might play a regulatory 
role in the redundant regulatory mechanisms to maintain energy homeostasis through multiple 
signaling pathways. 
Our model for PASKIN activation could to some extent be confirmed, since an obvious 
phenotype arises when the Paskin-/- mice are challenged by HFD. Only under HFD, when the 
phosphorylation of AMPK is decreased [185], Paskin-/- mice can maintain AMPK 
phosphorylation due to the lack of PASKIN dependent inhibition. So far, there is no evidence 
that PASKIN directly inhibits AMPK phosphorylation or interacts with AMPK. Peptide and 
protein arrays were screened in our lab for novel phosphorylation targets of PASKIN. 
However AMPK was not detected. Therefore, an in vitro phosphorylation or co-
immunoprecipitation assay is necessary to gain more insight into the molecular interplay of 
PASKIN with AMPK and to find out whether PASKIN can phosphorylate and thereby inhibit 
AMPK. Another approach would be to see whether an activator of AMPK, like LKB1 or 
PPARδ [186] are as well able to be phosphorylated by or interact with PASKIN. Furthermore, 
it might be that the regulation of PASKIN implies the melanocortin system. Melanocortin can 
potently restore AMPK phosphorylation in skeletal muscle of HFD fed mice [185]. 
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Intracerebroventricular treatment with a melanocortin antagonist of HFD fed Paskin-/- mice 
would provide an insight whether PASKIN affects the central regulation of skeletal muscle 
AMPK activity. Antecedent it would make sense to check PASKIN expression in the brain 
stem, where endogenous agonists of melanocortin are synthesized [187]. Possibilities to see 
significant differences between Paskin+/+ and Paskin-/- mice fed HFD would imply to apply 
more stringent stress conditions, i.e. to increase the fat-diet to 60% fat by calories. 
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8 CONCLUSIONS 
PASKIN as a novel PAS serine/threonine kinase might participate in a multitude of cellular 
processes. The ubiquitous expression, the AMP-kinase related kinase domain and the high 
similarity to the FixL PAS domain, suggest PASKIN as a mammalian cellular sensor protein. 
Indeed, using protein and peptide arrays we identified possible phosphorylation targets which 
are involved in spermatogenesis, glycolysis, and glycogen metabolism. The present work 
brings together all these aspects and specifically addresses a role for PASKIN in whole body 
energy metabolism. 
The function of PASKIN in the testis might so far be the most obscure question to be solved. 
Although PASKIN is most prominently expressed in the testis, even after backcrossing into a 
homogenous C57BL/6 background, neither impaired fertility nor other apparent phenotypes 
arose. Measurement of testosterone levels or the determination of apoptosis in seminiferous 
tubuli in vitro were not yet successful. Interestingly, it has been reported, that insulin and 
leptin are expressed in and secreted by human ejaculated spermatozoa [188]. Ando et al. 
assume that leptin and insulin are needed to manage the energy status in ejaculated 
spermatozoa. Surprisingly, PASKIN and insulin are located in the midpiece of the 
uncapacitated spermatozoa.  
We could show, that hyperglycemia is neither increasing PASKIN mRNA nor protein in 
pancreatic islet β-cells. Not only PASKIN mRNA levels but also kinase activity was reported 
to be induced by high glucose. We disproved this by showing that neither glucose induction 
of insulin mRNA nor insulin secretion was dependent on the presence of a functional 
PASKIN gene. In vivo experiments like glucose and insulin tolerance tests performed with 
both genders and variously aged Paskin+/+ and Paskin-/- mice further underline that PASKIN 
is not implicated in insulin secretion or production. A function for PASKIN in the immediate 
answer of insulin secretion can therefore be excluded. In addition, we did not detect PASKIN 
mRNA levels in pancreas neither in islet β-cells. 
The administration of high fat diet to Paskin+/+ and Paskin-/- mice shed light on a possible 
implication of PASKIN in energy homeostasis. HFD-fed Paskin-/- mice are not gaining weight 
to the same extent as HFD-fed Paskin+/+ mice. Indeed, the significantly heavier NCD-fed 
Paskin-/- mice, when compared to NCD-fed Paskin+/+ mice, turn into the lighter weighing 
group once HFD is applied to Paskin+/+ and Paskin-/- mice. We assume that the differences in 
body weight derives from a higher body fat content of the HFD-fed Paskin+/+ mice which 
show an increased level of triglyceride in their blood plasma when compared to the HFD-fed 
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Paskin-/- male mice. The glucose clearing ability in Paskin+/+ mice was significantly lower 
versus Paskin-/- mice, pointing towards a role for PASKIN in maintaining the balance in 
energy homeostasis. This leads to the question: What might be the counterplayer of PASKIN? 
AMPK phosphorylation was found to be increased in Paskin-/- mouse embryonic fibroblasts, 
although AMPK has abundant regulatory effects in energy homeostasis and it is a difficult 
task to solve the effect PASKIN exerts on the signaling pathway of AMPK. AMPK signaling 
pathway and the insulin signaling pathway share common as well as opposite regulatory 
mechanisms (see introduction). This might be an explanation why PASKIN was thought to 
play a role in pancreatic islet β-cells. Other factors like cell culture handling and discrepancies 
arising when validating in vitro results with in vivo experiments, were contributing to the 
results concerning PASKIN function in pancreatic islet β-cells presented in this work. 
The significantly decreased running activity of Paskin-/- might lead towards a role for 
PASKIN in skeletal muscle. Since AMPK can easily be stimulated by exercise, either in vivo 
or in vitro experiments will shed light on possible implication of PASKIN in the metabolism 
of skeletal muscle. Another hint that PASKIN might play a role in skeletal muscle is its 
putative interaction partner Ryanodine receptor 2 which belongs to a class of calcium 
channels in various forms of muscle and other excitable animal tissue (Eckhardt K., Wenger 
R.H.; unpublished data). Ryanodine receptors (RyRs) are the major cellular mediator of 
calcium induced calcium release in animal cells. 
In conclusion, we found that PASKIN deletion suppresses phenotypes associated with a high-
fat diet. Thus we assume the involvement of PASKIN in keeping the energy balance. To 
elucidate the exact mechanism of PASKIN action on cellular level further in vivo and in vitro 
experiments are required. Whether PASKIN interacts with AMPK or PARPδ remains to be 
elucidated, however we suggest a role for PASKIN in metabolic energy homeostasis. 
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